sampleid	submitted_name	run_prefix	experimental_strategy	cgc_base_name	filename	analyte_amount	analyte_A260A280Ratio	aliquot_concentration	cgc_id	cgc_filename	vital_status	gender	race	ethnicity	disease_type	data_subtype	tcga_sample_id	cgc_case_uuid	sample_type	cgc_platform	gdc_file_uuid	primary_site	age_at_diagnosis	cgc_sample_uuid	cgc_aliquot_uuid	tcga_aliquot_id	reference_genome	tcga_case_id	investigation	days_to_death	knightlabID	data_submitting_center_label	tissue_source_site_label	country_of_sample_procurement	portion_is_ffpe	pathologic_t_label	pathologic_n_label	histological_diagnosis_label	pathologic_stage_label	PlateCenter	PlateCenterFlag
13722.58cfa82de4b0c9d6adf6a4c2	58cfa82de4b0c9d6adf6a4c2	12dd02ea14d0a87df23ce3bef406fe27.filtered.	WGS	12dd02ea14d0a87df23ce3bef406fe27	12dd02ea14d0a87df23ce3bef406fe27.bam	32.75	NA	0.08	58cfa82de4b0c9d6adf6a4c2	12dd02ea14d0a87df23ce3bef406fe27.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I1-01A	5DD423E8-FEAA-4568-A750-500948C41D6C	Primary Tumor	Illumina HiSeq	30cac8b3-f09f-4eeb-8dff-e77e8b9c13fd	Breast	73	2A5F4696-6E02-4FE9-B66D-8C2AE93B7C2F	2290B078-6A5B-4C83-9DFB-B525BBF14E4E	TCGA-B6-A0I1-01A-11D-A21Q-09	GRCh37-lite	TCGA-B6-A0I1	TCGA-BRCA	2361	s5473	Washington University School of Medicine	Duke	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a502	58cfa82de4b0c9d6adf6a502	3d9f475186150ea055fddf25af7bb7e3.filtered.	WGS	3d9f475186150ea055fddf25af7bb7e3	3d9f475186150ea055fddf25af7bb7e3.bam	64.35	1.7	0.08	58cfa82de4b0c9d6adf6a502	3d9f475186150ea055fddf25af7bb7e3.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EY-A1GW-01A	F8AC5FD2-11F2-4B3A-A3A6-FF1A6D8E1CAE	Primary Tumor	Illumina HiSeq	b2829fb0-5912-46cd-a87b-e2dcbb14192d	Uterus	73	22CB3D87-7FAB-419A-B071-1ADC6B810719	EC31E921-0782-4F77-AC23-4190AF1E61EE	TCGA-EY-A1GW-01A-22D-A13L-09	GRCh37-lite	TCGA-EY-A1GW	TCGA-UCEC	NA	s4407	Washington University School of Medicine	University of North Carolina	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A13L-09	FALSE
13722.58cfa82de4b0c9d6adf6a4ce	58cfa82de4b0c9d6adf6a4ce	2258e57e8e0af9db6969a1da86177ca7.filtered.	WGS	2258e57e8e0af9db6969a1da86177ca7	2258e57e8e0af9db6969a1da86177ca7.bam	62.02	2.08	0.08	58cfa82de4b0c9d6adf6a4ce	2258e57e8e0af9db6969a1da86177ca7.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A03L-01A	1174F6E4-FFBE-4E59-A000-8D861C968369	Primary Tumor	Illumina HiSeq	e374014a-934d-4eee-b1e3-53ec285ea08e	Breast	34	00F81E98-E5C3-43B2-9757-F769EC17F3F8	8F558713-F32B-403B-AEDF-C79EFEB41C67	TCGA-AO-A03L-01A-41D-A19H-09	GRCh37-lite	TCGA-AO-A03L	TCGA-BRCA	NA	s6617	Washington University School of Medicine	MSKCC	None	NO	T3	N2	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a48a	58cfa82de4b0c9d6adf6a48a	142ba22e796cab1075278cd533a287c8.filtered.	WGS	142ba22e796cab1075278cd533a287c8	142ba22e796cab1075278cd533a287c8.bam	93.54	2.18	0.07	58cfa82de4b0c9d6adf6a48a	142ba22e796cab1075278cd533a287c8.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0L9-01A	7B9947D5-E86B-4006-8890-EA5209584A88	Primary Tumor	Illumina HiSeq	56ea48ea-3024-42a8-9753-85711f00712f	Uterus	71	53D0521F-10D6-4F70-9277-D99025A6B963	2B78DE4E-4C8B-4ADF-A058-3DAE797E7881	TCGA-AP-A0L9-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0L9	TCGA-UCEC	NA	s4234	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa82de4b0c9d6adf6a4d4	58cfa82de4b0c9d6adf6a4d4	406aecbc23505359850e57fbf05d5b67.filtered.	WGS	406aecbc23505359850e57fbf05d5b67	406aecbc23505359850e57fbf05d5b67.bam	85.32	1.85	0.08	58cfa82de4b0c9d6adf6a4d4	406aecbc23505359850e57fbf05d5b67.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LI-01A	E1E8DC66-467C-48A5-BE56-3DB4F665B9F1	Primary Tumor	Illumina HiSeq	626ae092-ba0a-4c13-b860-b407436bc53b	Uterus	67	981D9E3B-63C5-41E9-827F-7F1D268D62F4	DEC775C5-7D9A-4DC5-B399-DC4B7BA49D73	TCGA-AP-A0LI-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0LI	TCGA-UCEC	NA	s5189	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa82de4b0c9d6adf6a529	58cfa82de4b0c9d6adf6a529	4aa512860ab86fb3f56ebdc8fcd69ce1.filtered.	WGS	4aa512860ab86fb3f56ebdc8fcd69ce1	4aa512860ab86fb3f56ebdc8fcd69ce1.bam	116.74	2	0.08	58cfa82de4b0c9d6adf6a529	4aa512860ab86fb3f56ebdc8fcd69ce1.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LE-01A	DCFF8659-ECCA-4798-80A3-DD6E7642BA2B	Primary Tumor	Illumina HiSeq	b5fe9da4-e8c6-4c5a-ae7f-b1227dcafe8f	Uterus	57	9C4A32CF-DE40-4996-91A9-56F1C18D69A4	638E80C7-9A6E-4A32-A621-FC4168E72343	TCGA-AP-A0LE-01A-11D-A127-09	GRCh37-lite	TCGA-AP-A0LE	TCGA-UCEC	NA	s4982	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A127-09	FALSE
13722.58cfa82de4b0c9d6adf6a46d	58cfa82de4b0c9d6adf6a46d	0434f7930c67bd9c412cb31f2ada0466.filtered.	WGS	0434f7930c67bd9c412cb31f2ada0466	0434f7930c67bd9c412cb31f2ada0466.bam	27.89	1.93	0.08	58cfa82de4b0c9d6adf6a46d	0434f7930c67bd9c412cb31f2ada0466.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A18R-01A	F6E1EC78-5AD9-4879-9B7E-262D17B166AD	Primary Tumor	Illumina HiSeq	14062e7f-b11d-44a9-ae98-3383c517bf91	Breast	50	518BE2C7-FBA5-47B1-8C8B-FEF812FA74A4	9C70688D-6E43-4520-9262-EAAE4E4D597D	TCGA-BH-A18R-01A-11D-A19H-09	GRCh37-lite	TCGA-BH-A18R	TCGA-BRCA	1142	s6259	Washington University School of Medicine	University of Pittsburgh	None	NO	T2b	N1	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a52c	58cfa82de4b0c9d6adf6a52c	08f5ca11eae517c5ad7ce14a801eaf99.filtered.	WGS	08f5ca11eae517c5ad7ce14a801eaf99	08f5ca11eae517c5ad7ce14a801eaf99.bam	46.2	1.89	0.07	58cfa82de4b0c9d6adf6a52c	08f5ca11eae517c5ad7ce14a801eaf99.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A07I-01A	566792AE-F853-4A47-856D-F02CDCFCB18A	Primary Tumor	Illumina HiSeq	6453f2d2-c0d0-46ee-a131-4a59788bb4c3	Breast	69	0D2E50FA-DAEF-45A3-97B2-5D71AB03CFBF	A6C14EBC-81A2-44F7-AF87-2B7EC85E5696	TCGA-A8-A07I-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A07I	TCGA-BRCA	NA	s5784	Washington University School of Medicine	Indivumed	Germany	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a542	58cfa82de4b0c9d6adf6a542	161c6ea1a81d271566d819bb40703564.filtered.	WGS	161c6ea1a81d271566d819bb40703564	161c6ea1a81d271566d819bb40703564.bam	71.74	1.98	0.09	58cfa82de4b0c9d6adf6a542	161c6ea1a81d271566d819bb40703564.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A18C-01A	66E305CA-8A16-44F0-B837-85E529B7AD55	Primary Tumor	Illumina HiSeq	358cf81d-1664-4a81-9bdc-eddc1d95f8f4	Uterus	72	37F209B1-C738-441C-B205-EAEC4E2ADE4E	6E599FCC-D79A-4E0F-B451-C20768C989F9	TCGA-BG-A18C-01A-11D-A325-09	GRCh37-lite	TCGA-BG-A18C	TCGA-UCEC	NA	s5187	Washington University School of Medicine	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A325-09	TRUE
13722.58cfa82de4b0c9d6adf6a59b	58cfa82de4b0c9d6adf6a59b	63caf3c72c859d6a05579c2a05cead25.filtered.	WGS	63caf3c72c859d6a05579c2a05cead25	63caf3c72c859d6a05579c2a05cead25.bam	32.95	NA	0.08	58cfa82de4b0c9d6adf6a59b	63caf3c72c859d6a05579c2a05cead25.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A3XL-01A	65CAC997-4D39-4501-85EC-4FCB328A8EB5	Primary Tumor	Illumina HiSeq	77d3443d-1bf9-4867-89a2-65cc8e10141b	Breast	49	FED3A891-21BE-4196-B9EF-0BF7C8F976AA	B27D75BA-5989-4200-BFE9-F1B7D7CF8008	TCGA-GM-A3XL-01A-11D-A22X-09	GRCh37-lite	TCGA-GM-A3XL	TCGA-BRCA	NA	s6264	Washington University School of Medicine	MD Anderson	United States	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A22X-09	FALSE
13722.58cfa82de4b0c9d6adf6a580	58cfa82de4b0c9d6adf6a580	2db39072c0d1914dea2d317877070812.filtered.	WGS	2db39072c0d1914dea2d317877070812	2db39072c0d1914dea2d317877070812.bam	81.48	1.85	0.08	58cfa82de4b0c9d6adf6a580	2db39072c0d1914dea2d317877070812.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I2-01A	328DFCB0-B5AE-43F2-BC87-DAD0AB3DF9E7	Primary Tumor	Illumina HiSeq	1f31bdc1-69ef-49bf-8200-d73661b23c67	Breast	45	47436CE0-438F-475B-AC0D-1972D0C5285E	A2D9325E-DA9D-42F1-A360-328D17ED492B	TCGA-B6-A0I2-01A-11D-A12L-09	GRCh37-lite	TCGA-B6-A0I2	TCGA-BRCA	NA	s5788	Washington University School of Medicine	Duke	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A12L-09	FALSE
13722.58cfa82de4b0c9d6adf6a556	58cfa82de4b0c9d6adf6a556	063d6bdd81ba674cf8ce55970b76bc7d.filtered.	WGS	063d6bdd81ba674cf8ce55970b76bc7d	063d6bdd81ba674cf8ce55970b76bc7d.bam	NA	NA	0.08	58cfa82de4b0c9d6adf6a556	063d6bdd81ba674cf8ce55970b76bc7d.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A05S-01A	3A4A6AFF-4720-41FC-A114-85F38610EBB1	Primary Tumor	Illumina HiSeq	982e6db1-dd32-43ea-821b-612393624334	Uterus	81	3D8F263F-6866-4B92-AAEE-743EC5514865	C082DC34-457E-40EC-8258-E11E8ED362C2	TCGA-AX-A05S-01A-11D-A013-09	GRCh37-lite	TCGA-AX-A05S	TCGA-UCEC	413	s5186	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa82de4b0c9d6adf6a548	58cfa82de4b0c9d6adf6a548	0d9ef8b814476b334be08fe7ee6ea88c.filtered.	WGS	0d9ef8b814476b334be08fe7ee6ea88c	0d9ef8b814476b334be08fe7ee6ea88c.bam	66.73	2.23	0.07	58cfa82de4b0c9d6adf6a548	0d9ef8b814476b334be08fe7ee6ea88c.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A075-01A	7861A5F2-8910-4BCB-9C34-F79C5ACD6E21	Primary Tumor	Illumina HiSeq	4d604b9e-e0ae-4c4e-b844-4c1d7924d75b	Breast	42	D3263082-946D-4420-8A63-8D67EEEE09C5	6C8E9197-FD16-4FED-BFDA-E349CAB26314	TCGA-A8-A075-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A075	TCGA-BRCA	NA	s6451	Washington University School of Medicine	Indivumed	Germany	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a5a6	58cfa82de4b0c9d6adf6a5a6	5e03098f26dc684c1f21cc0094f04543.filtered.	WGS	5e03098f26dc684c1f21cc0094f04543	5e03098f26dc684c1f21cc0094f04543.bam	27.49	NA	0.08	58cfa82de4b0c9d6adf6a5a6	5e03098f26dc684c1f21cc0094f04543.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3U6-01A	6201394F-B70E-4F14-9519-FF9D5F06EB09	Primary Tumor	Illumina HiSeq	d62aa69c-0aa5-4eab-b882-d3aca07cdd27	Mesenchymal	63	ACEA4025-F740-4A60-AD51-EAF61964256B	DB650EFF-4E2C-4CE3-9124-7697B6E03359	TCGA-DX-A3U6-01A-11D-A29N-09	GRCh37-lite	TCGA-DX-A3U6	TCGA-SARC	NA	s2341	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A29N-09	FALSE
13722.58cfa82de4b0c9d6adf6a59d	58cfa82de4b0c9d6adf6a59d	6507fcb7033a99eba7d09d1768996237.filtered.	WGS	6507fcb7033a99eba7d09d1768996237	6507fcb7033a99eba7d09d1768996237.bam	128.45	2.03	0.08	58cfa82de4b0c9d6adf6a59d	6507fcb7033a99eba7d09d1768996237.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0L8-01A	9AA8C2B4-DB32-4899-BF0C-D578CB175E90	Primary Tumor	Illumina HiSeq	13a692ca-4d87-484b-aec0-1562b201470f	Uterus	70	D1A7A58F-7A35-4A94-A337-051AE56DED00	15D597DE-D26C-4CE1-B0CB-077E39B55F30	TCGA-AP-A0L8-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0L8	TCGA-UCEC	1484	s5378	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa82de4b0c9d6adf6a546	58cfa82de4b0c9d6adf6a546	0efe658adac35f9288ebc6e59891a34b.filtered.	WGS	0efe658adac35f9288ebc6e59891a34b	0efe658adac35f9288ebc6e59891a34b.bam	66.38	2	0.08	58cfa82de4b0c9d6adf6a546	0efe658adac35f9288ebc6e59891a34b.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A05A-01A	C350B53B-3C27-4B9E-8B57-D7B6A1205A1F	Primary Tumor	Illumina HiSeq	1e8db39a-fb8e-4aa5-8cce-962a219e02e7	Uterus	81	482153FB-E69D-4748-9CF4-E281EC141518	99696731-C88F-427B-975B-1D90013E63FF	TCGA-AP-A05A-01A-11D-A013-09	GRCh37-lite	TCGA-AP-A05A	TCGA-UCEC	NA	s4980	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa82de4b0c9d6adf6a572	58cfa82de4b0c9d6adf6a572	29d8acadae6e2c6643400b1090ef29f2.filtered.	WGS	29d8acadae6e2c6643400b1090ef29f2	29d8acadae6e2c6643400b1090ef29f2.bam	61.59	1.88	0.08	58cfa82de4b0c9d6adf6a572	29d8acadae6e2c6643400b1090ef29f2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A1-A0SM-01A	784DE7AC-8424-42EB-83D4-A1BEBAA42B97	Primary Tumor	Illumina HiSeq	d1b482b0-0e66-4620-bc89-bfc93541735d	Breast	77	289F5433-4834-401F-9361-EFC8E883E630	546B982F-60D9-43DF-9761-09369AFBEE2D	TCGA-A1-A0SM-01A-11D-A19H-09	GRCh37-lite	TCGA-A1-A0SM	TCGA-BRCA	NA	s6111	Washington University School of Medicine	UCSF	United States	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a5f2	58cfa82de4b0c9d6adf6a5f2	58c9640b867e208cc0db2f7a975b1c51.filtered.	WGS	58c9640b867e208cc0db2f7a975b1c51	58c9640b867e208cc0db2f7a975b1c51.bam	48.69	2.02	0.08	58cfa82de4b0c9d6adf6a5f2	58c9640b867e208cc0db2f7a975b1c51.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DT-01A	74F31744-0AED-4633-BEEC-4E203315F0B7	Primary Tumor	Illumina HiSeq	4ac2ec89-0e27-40ab-949e-6cb716b4d9e1	Breast	41	EB11D414-2F0E-44A1-843C-ECACC7212E91	30DBE353-86D5-40ED-84C2-DBDDF7BEB17B	TCGA-BH-A0DT-01A-21D-A12B-09	GRCh37-lite	TCGA-BH-A0DT	TCGA-BRCA	NA	s5480	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A12B-09	FALSE
13722.58cfa82de4b0c9d6adf6a656	58cfa82de4b0c9d6adf6a656	801434f25120f36fe582c7906500e08e.filtered.	WGS	801434f25120f36fe582c7906500e08e	801434f25120f36fe582c7906500e08e.bam	21.21	NA	0.08	58cfa82de4b0c9d6adf6a656	801434f25120f36fe582c7906500e08e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3KC-01A	2D29A4AC-98E7-4663-9DD6-5681BC32AC2E	Primary Tumor	Illumina HiSeq	449d2c68-674e-4e86-89ff-574170845aa1	Breast	55	8318A9A4-E78E-4DB8-97C7-2CC733D0C512	F9F04E42-63A2-4EE1-ADE4-9E5BB5C20CDD	TCGA-A2-A3KC-01A-11D-A20S-09	GRCh37-lite	TCGA-A2-A3KC	TCGA-BRCA	NA	s5952	Washington University School of Medicine	Walter Reed	United States	NO	T2	N1a	Infiltrating Lobular Carcinoma	Stage IIB	A20S-09	FALSE
13722.58cfa82de4b0c9d6adf6a5d4	58cfa82de4b0c9d6adf6a5d4	5b90de51bbfaf67cf060a869713e0324.filtered.	WGS	5b90de51bbfaf67cf060a869713e0324	5b90de51bbfaf67cf060a869713e0324.bam	56.64	1.95	0.08	58cfa82de4b0c9d6adf6a5d4	5b90de51bbfaf67cf060a869713e0324.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A152-01A	A8015490-9740-45C9-8BD2-EB6D1BEEFC2E	Primary Tumor	Illumina HiSeq	fe904377-4375-437b-8774-c80f11c6e0ff	Breast	56	0EF32921-BB7A-4055-A6ED-E8CED5F824E4	8691C87F-2468-44BB-A670-3DCCD6DA33C6	TCGA-E2-A152-01A-11D-A19H-09	GRCh37-lite	TCGA-E2-A152	TCGA-BRCA	NA	s6915	Washington University School of Medicine	Roswell Park	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a610	58cfa82de4b0c9d6adf6a610	6e5cc39dc99c646350c2188f42625edd.filtered.	WGS	6e5cc39dc99c646350c2188f42625edd	6e5cc39dc99c646350c2188f42625edd.bam	59.06	1.95	0.08	58cfa82de4b0c9d6adf6a610	6e5cc39dc99c646350c2188f42625edd.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A0TN-01A	14C65927-B9DD-4EF6-9917-DB7BC431FF2F	Primary Tumor	Illumina HiSeq	f860da6f-1cec-4913-aa35-b32670a1734f	Cervix	21	59B0B757-7D08-4B3E-9974-FD02747D3665	945E6808-2887-4F32-AC32-8F9E00353BF6	TCGA-C5-A0TN-01A-21D-A200-09	GRCh37-lite	TCGA-C5-A0TN	TCGA-CESC	348	s1165	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b	N1	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a66b	58cfa82de4b0c9d6adf6a66b	6f9e6813a75e86e0dd1890966a4457d9.filtered.	WGS	6f9e6813a75e86e0dd1890966a4457d9	6f9e6813a75e86e0dd1890966a4457d9.bam	66.32	1.9	0.07	58cfa82de4b0c9d6adf6a66b	6f9e6813a75e86e0dd1890966a4457d9.bam	Alive	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0U9-01B	5FFA2EC6-2D94-4B09-8FB9-3591CF38FA4F	Primary Tumor	Illumina HiSeq	47ea3545-65e4-4c78-8780-1377ec259db5	Uterus	59	99D6D536-AF2C-4C9B-9995-5B4032D54479	82BE6087-A491-42D4-9B48-6A10D1BACE18	TCGA-BS-A0U9-01B-21D-A10M-09	GRCh37-lite	TCGA-BS-A0U9	TCGA-UCEC	NA	s4413	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10M-09	FALSE
13722.58cfa82de4b0c9d6adf6a624	58cfa82de4b0c9d6adf6a624	52a567ba68a991f7946cfbf0a1803a67.filtered.	WGS	52a567ba68a991f7946cfbf0a1803a67	52a567ba68a991f7946cfbf0a1803a67.bam	71.56	1.94	0.09	58cfa82de4b0c9d6adf6a624	52a567ba68a991f7946cfbf0a1803a67.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EY-A1GS-01A	C10B2885-70EA-4D32-BC48-8B85530DF702	Primary Tumor	Illumina HiSeq	e36825eb-c127-473a-a3d0-8c56a941a1a6	Uterus	71	99540910-61A1-434B-9937-216DFAC5F719	0C39C03A-EC84-42C6-BE69-8E98BC7A9F5A	TCGA-EY-A1GS-01A-11D-A13L-09	GRCh37-lite	TCGA-EY-A1GS	TCGA-UCEC	NA	s4236	Washington University School of Medicine	University of North Carolina	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A13L-09	FALSE
13722.58cfa82de4b0c9d6adf6a60e	58cfa82de4b0c9d6adf6a60e	52cd8d256fb4230a57b9973428e5d8a4.filtered.	WGS	52cd8d256fb4230a57b9973428e5d8a4	52cd8d256fb4230a57b9973428e5d8a4.bam	35.28	1.85	0.07	58cfa82de4b0c9d6adf6a60e	52cd8d256fb4230a57b9973428e5d8a4.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A092-01A	38A8B734-9ACC-42F9-B5B7-E51B0DFC6504	Primary Tumor	Illumina HiSeq	3a2d527a-e52b-426a-aad8-0a7691cf835b	Breast	48	8B5C7E4D-A220-4499-9E38-7DEACC1776A2	CC4F9175-A8C8-424A-99D7-8BD11CAE0E52	TCGA-A8-A092-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A092	TCGA-BRCA	NA	s6262	Washington University School of Medicine	Indivumed	Germany	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a676	58cfa82de4b0c9d6adf6a676	6e7789618e7259fb52cad2908f02f68b.filtered.	WGS	6e7789618e7259fb52cad2908f02f68b	6e7789618e7259fb52cad2908f02f68b.bam	43.84	1.95	0.08	58cfa82de4b0c9d6adf6a676	6e7789618e7259fb52cad2908f02f68b.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A052-01A	BD4284A7-260D-48B3-9B48-A1C578C30D27	Primary Tumor	Illumina HiSeq	94e31842-d1e3-47ad-bee2-70890b17580f	Uterus	59	33C21DCA-F3B3-48CD-9FC5-AD316598F23E	C75CC75A-7496-420F-B526-EA63C77E9839	TCGA-AP-A052-01A-11D-A013-09	GRCh37-lite	TCGA-AP-A052	TCGA-UCEC	669	s4769	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa82de4b0c9d6adf6a6c0	58cfa82de4b0c9d6adf6a6c0	869d810ce565d6181a7a0471f851fd20.filtered.	WGS	869d810ce565d6181a7a0471f851fd20	869d810ce565d6181a7a0471f851fd20.bam	107.78	2.13	0.09	58cfa82de4b0c9d6adf6a6c0	869d810ce565d6181a7a0471f851fd20.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K8-01A	24118B8F-59FE-482A-AED3-7B1BDE1571B7	Primary Tumor	Illumina HiSeq	48423c41-27b2-43d8-8358-735f4bcd008a	Uterus	71	66184035-AF3E-4C2B-901A-0709C49DC54E	554B9439-7E11-43EC-8BC3-448C59100B9E	TCGA-B5-A0K8-01A-11D-A14K-09	GRCh37-lite	TCGA-B5-A0K8	TCGA-UCEC	NA	s4415	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A14K-09	FALSE
13722.58cfa82de4b0c9d6adf6a6d6	58cfa82de4b0c9d6adf6a6d6	91d578e349e51da30596c416f3e08405.filtered.	WGS	91d578e349e51da30596c416f3e08405	91d578e349e51da30596c416f3e08405.bam	56.8	1.82	0.08	58cfa82de4b0c9d6adf6a6d6	91d578e349e51da30596c416f3e08405.bam	Dead	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1ML-01A	374F614A-BCD1-4283-AC6F-FC27DDC79987	Primary Tumor	Illumina HiSeq	897d140f-721c-4162-9f3e-e8b883560558	Cervix	49	F5495789-2C61-42F2-B6B6-A14E00D2F985	F658C350-FB89-4268-8A59-A07E365F4221	TCGA-C5-A1ML-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1ML	TCGA-CESC	636	s1355	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a6ec	58cfa82de4b0c9d6adf6a6ec	9730009cb05430035cc9988462351cef.filtered.	WGS	9730009cb05430035cc9988462351cef	9730009cb05430035cc9988462351cef.bam	38.58	2.02	0.08	58cfa82de4b0c9d6adf6a6ec	9730009cb05430035cc9988462351cef.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A0TX-01A	C364E81C-EB1E-4870-AB37-9C661F5F2E3D	Primary Tumor	Illumina HiSeq	e9fddd42-1948-4df8-ac61-4db49de8123f	Breast	64	D5ADAF35-04B1-4198-B308-F4720B3D6417	DDC7377D-82C3-480A-BE3C-3D1DA52C77D4	TCGA-AR-A0TX-01A-11D-A19H-09	GRCh37-lite	TCGA-AR-A0TX	TCGA-BRCA	NA	s5632	Washington University School of Medicine	Mayo	None	NO	T1	N1	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a70c	58cfa82de4b0c9d6adf6a70c	9fd4a7bb1756a87afb37ac7a45bbe196.filtered.	WGS	9fd4a7bb1756a87afb37ac7a45bbe196	9fd4a7bb1756a87afb37ac7a45bbe196.bam	56.47	1.91	0.09	58cfa82de4b0c9d6adf6a70c	9fd4a7bb1756a87afb37ac7a45bbe196.bam	Dead	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1BF-01B	262311A0-7A10-4934-8FBA-11EE581AD738	Primary Tumor	Illumina HiSeq	913cddd8-a6ed-4824-8b2c-02f3160028d6	Cervix	46	37670DB3-74D9-4176-BC34-65D2E062D1CB	7DC3E035-C7AE-4164-A62B-9C2460812B05	TCGA-C5-A1BF-01B-11D-A200-09	GRCh37-lite	TCGA-C5-A1BF	TCGA-CESC	570	s1169	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	TX	N0	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a6e0	58cfa82de4b0c9d6adf6a6e0	8acca8432df87fc66fbf834556f68a20.filtered.	WGS	8acca8432df87fc66fbf834556f68a20	8acca8432df87fc66fbf834556f68a20.bam	92.82	1.95	0.08	58cfa82de4b0c9d6adf6a6e0	8acca8432df87fc66fbf834556f68a20.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04X-01A	733A2A0F-B37A-4B81-B49E-3C0F30D1EB37	Primary Tumor	Illumina HiSeq	055e605f-56b9-4ca6-8856-1f32ab8e34a6	Breast	34	ABFF5667-7EF4-46C1-AD34-CEABC27E7992	41F140B8-72B9-4AE3-8B25-6144D9F94D0F	TCGA-A2-A04X-01A-21D-A19H-09	GRCh37-lite	TCGA-A2-A04X	TCGA-BRCA	NA	s6767	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf72ec2	58cfa83ce4b0c9d6adf72ec2	cf3a026c76b42c90171b25f03c7b18ad.filtered.	WGS	cf3a026c76b42c90171b25f03c7b18ad	cf3a026c76b42c90171b25f03c7b18ad.bam	68.2	1.89	0.07	58cfa83ce4b0c9d6adf72ec2	cf3a026c76b42c90171b25f03c7b18ad.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0CM-01A	EB2DBB4F-66B6-4525-8323-431970F7A64E	Primary Tumor	Illumina HiSeq	a6c27294-bf51-4eac-a2b6-885f5757b32b	Breast	40	EA7FB858-C17B-40D4-9A22-CBD9DA614B65	4B9CBBE5-CBD6-4CDE-853A-FA96A176E86D	TCGA-A2-A0CM-01A-31D-A128-09	GRCh37-lite	TCGA-A2-A0CM	TCGA-BRCA	754	s6255	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf72e98	58cfa83ce4b0c9d6adf72e98	c7785537c59d3349dd69e0f8e87266b7.filtered.	WGS	c7785537c59d3349dd69e0f8e87266b7	c7785537c59d3349dd69e0f8e87266b7.bam	27.86	1.93	0.08	58cfa83ce4b0c9d6adf72e98	c7785537c59d3349dd69e0f8e87266b7.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LL-01A	2A84997D-CCEE-4F46-BEA2-752534F26416	Primary Tumor	Illumina HiSeq	85360168-d41d-4201-8416-2cb4b45fca0f	Breast	73	E57574E4-7E01-4E61-BD29-EE4EC63DDDD6	47312F61-5EF4-4F25-9320-8FBB4758790E	TCGA-E2-A1LL-01A-11D-A142-09	GRCh37-lite	TCGA-E2-A1LL	TCGA-BRCA	NA	s5780	Washington University School of Medicine	Roswell Park	United States	NO	T3	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A142-09	FALSE
13722.58cfa83ce4b0c9d6adf72ee4	58cfa83ce4b0c9d6adf72ee4	d8812a052472972b8c4ec509bc9bec1f.filtered.	WGS	d8812a052472972b8c4ec509bc9bec1f	d8812a052472972b8c4ec509bc9bec1f.bam	70.78	1.98	0.08	58cfa83ce4b0c9d6adf72ee4	d8812a052472972b8c4ec509bc9bec1f.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A06B-01A	95E6D327-9AB7-45DE-9527-F5634B3995C3	Primary Tumor	Illumina HiSeq	4f89c64d-ad85-45a6-a62b-e78fcbe761b3	Uterus	72	A43F90B7-4A6C-423C-82DE-AD2C330AE0FB	55ADA396-0878-4724-8EBE-00DA367EED3D	TCGA-AX-A06B-01A-11D-A325-09	GRCh37-lite	TCGA-AX-A06B	TCGA-UCEC	NA	s4974	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A325-09	TRUE
13722.58cfa83ce4b0c9d6adf72fd0	58cfa83ce4b0c9d6adf72fd0	b2efe67d968c5b6634b971bdef73c05a.filtered.	WGS	b2efe67d968c5b6634b971bdef73c05a	b2efe67d968c5b6634b971bdef73c05a.bam	60.09	1.81	0.07	58cfa83ce4b0c9d6adf72fd0	b2efe67d968c5b6634b971bdef73c05a.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A11H-01A	DEE43082-4AA7-4650-981C-A779E9FE7B55	Primary Tumor	Illumina HiSeq	f7538b9e-e9b1-41fd-b09d-9ef50a3553d5	Uterus	67	D78D2F6B-3EB3-4082-A7EA-F7B6202CDC58	ACCFC45B-EAE0-4991-A488-E217CDB46655	TCGA-B5-A11H-01A-11D-A122-09	GRCh37-lite	TCGA-B5-A11H	TCGA-UCEC	NA	s4571	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A122-09	TRUE
13722.58cfa83ce4b0c9d6adf72e96	58cfa83ce4b0c9d6adf72e96	c7084960dc3d5bdf5efebd6a16721e46.filtered.	WGS	c7084960dc3d5bdf5efebd6a16721e46	c7084960dc3d5bdf5efebd6a16721e46.bam	52.3	2.08	0.08	58cfa83ce4b0c9d6adf72e96	c7084960dc3d5bdf5efebd6a16721e46.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A08S-01A	2779FA01-AC93-4E80-A997-3385F72172C3	Primary Tumor	Illumina HiSeq	b026f426-bb3a-4c0e-b90d-6ec93bde0f53	Breast	71	960D194F-FE39-42A0-831D-5C031CF93544	2C6F1862-BB82-4E7E-9CB3-338BDF022FF4	TCGA-A8-A08S-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A08S	TCGA-BRCA	NA	s6252	Washington University School of Medicine	Indivumed	Germany	NO	T1c	N1	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf72fd8	58cfa83ce4b0c9d6adf72fd8	bcbfebca137feee918342e841c0bb404.filtered.	WGS	bcbfebca137feee918342e841c0bb404	bcbfebca137feee918342e841c0bb404.bam	93.85	1.93	0.08	58cfa83ce4b0c9d6adf72fd8	bcbfebca137feee918342e841c0bb404.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A1CI-01A	FBA80122-D8B2-4D8D-A032-9767E8160F9F	Primary Tumor	Illumina HiSeq	47f4dbcb-cbdc-4e4e-a4b2-5080f3e683cf	Uterus	61	DDD2F9E0-0AA3-425B-9D74-74FCC638CB08	92126163-00C3-41F2-9CE6-7AAD5F621407	TCGA-AX-A1CI-01A-11D-A135-09	GRCh37-lite	TCGA-AX-A1CI	TCGA-UCEC	NA	s4572	Washington University School of Medicine	Gynecologic Oncology Group	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A135-09	FALSE
13722.58cfa83ce4b0c9d6adf72ee6	58cfa83ce4b0c9d6adf72ee6	daf008933258f806fa354a9618f801be.filtered.	WGS	daf008933258f806fa354a9618f801be	daf008933258f806fa354a9618f801be.bam	62.71	NA	0.08	58cfa83ce4b0c9d6adf72ee6	daf008933258f806fa354a9618f801be.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2PK-01A	0809BA8B-4AB6-4F43-934C-C1CCBC014A7E	Primary Tumor	Illumina HiSeq	7109053e-8be0-4965-a5eb-a9bbab5ee53f	Cervix	43	5F613800-55DF-497F-A544-5B12CB9446CE	B3B3A27C-EE9A-42AF-A6D1-9AF5970A98B9	TCGA-EK-A2PK-01A-11D-A18J-09	GRCh37-lite	TCGA-EK-A2PK	TCGA-CESC	NA	s1506	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A18J-09	TRUE
13722.58cfa83ce4b0c9d6adf730f0	58cfa83ce4b0c9d6adf730f0	ed7c0d707af5e0862abe28d9bbea0aec.filtered.	WGS	ed7c0d707af5e0862abe28d9bbea0aec	ed7c0d707af5e0862abe28d9bbea0aec.bam	82.92	2	0.08	58cfa83ce4b0c9d6adf730f0	ed7c0d707af5e0862abe28d9bbea0aec.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GE-01A	A587E62E-430E-4F1B-82B7-6FBE856FDAF1	Primary Tumor	Illumina HiSeq	acd74d29-be09-40a4-b713-578d8469edd7	Uterus	38	20C3F64D-ACF6-45B3-9ACE-2F93B3A951C8	23CC70C4-B744-4FA0-A0DE-B25C0FDF212F	TCGA-A5-A0GE-01A-11D-A066-09	GRCh37-lite	TCGA-A5-A0GE	TCGA-UCEC	NA	s4765	Washington University School of Medicine	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf72f94	58cfa83ce4b0c9d6adf72f94	f45f02f7da5f0692a3a5e6f53061ff05.filtered.	WGS	f45f02f7da5f0692a3a5e6f53061ff05	f45f02f7da5f0692a3a5e6f53061ff05.bam	103.95	1.98	0.08	58cfa83ce4b0c9d6adf72f94	f45f02f7da5f0692a3a5e6f53061ff05.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A053-01A	AF37D8F0-FEA0-47F6-BE0A-2FB55A5DA5C4	Primary Tumor	Illumina HiSeq	f5bf0f66-e1e7-424f-90df-9ec48601cece	Uterus	90	E1121A9E-BC27-44EB-A1AD-EB0AB10B7C3A	B77084AB-8148-49E0-B3F9-90F7D9EA1862	TCGA-AP-A053-01A-21D-A013-09	GRCh37-lite	TCGA-AP-A053	TCGA-UCEC	NA	s4574	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa83ce4b0c9d6adf73120	58cfa83ce4b0c9d6adf73120	c4db7ecd250c14ade136a8948ac7149e.filtered.	WGS	c4db7ecd250c14ade136a8948ac7149e	c4db7ecd250c14ade136a8948ac7149e.bam	46.45	1.84	0.08	58cfa83ce4b0c9d6adf73120	c4db7ecd250c14ade136a8948ac7149e.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1J5-01A	5D8ED961-A012-4B6B-BFFB-9468D3953646	Primary Tumor	Illumina HiSeq	17593e20-8cc4-4961-8ff5-871806aeed93	Breast	59	BF42E8CE-CD3E-46C8-92F9-EA5CDA443A6F	98BB3025-0637-4106-8621-12DF7B5D662F	TCGA-EW-A1J5-01A-11D-A13L-09	GRCh37-lite	TCGA-EW-A1J5	TCGA-BRCA	NA	s6251	Washington University School of Medicine	University of Miami	United States	NO	T3	N0 (i-)	Infiltrating Lobular Carcinoma	Stage IIB	A13L-09	FALSE
13722.58cfa83ce4b0c9d6adf730e8	58cfa83ce4b0c9d6adf730e8	e05892d1ff93e157f1df1fbaf7b2de29.filtered.	WGS	e05892d1ff93e157f1df1fbaf7b2de29	e05892d1ff93e157f1df1fbaf7b2de29.bam	65.45	2.08	0.08	58cfa83ce4b0c9d6adf730e8	e05892d1ff93e157f1df1fbaf7b2de29.bam	Alive	FEMALE	Not available	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EO-A1Y8-01A	DE4E13C8-5AD0-46D2-AE54-B9CA22B939D8	Primary Tumor	Illumina HiSeq	9346f0a9-a615-49bc-997e-3ef137b190b7	Uterus	87	5B0A8519-3FEA-46D6-8F6D-EC85C403B416	EA6EFCD1-11DE-45F0-8BDE-F1C06AD27E79	TCGA-EO-A1Y8-01A-11D-A159-09	GRCh37-lite	TCGA-EO-A1Y8	TCGA-UCEC	NA	s4401	Washington University School of Medicine	University Health Network	Canada	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A159-09	FALSE
13722.58cfa83ce4b0c9d6adf72ea6	58cfa83ce4b0c9d6adf72ea6	d1ee2de36aac63e924ff27efa16ae3dc.filtered.	WGS	d1ee2de36aac63e924ff27efa16ae3dc	d1ee2de36aac63e924ff27efa16ae3dc.bam	94.43	2	0.08	58cfa83ce4b0c9d6adf72ea6	d1ee2de36aac63e924ff27efa16ae3dc.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LH-01A	7DCE4215-01F6-43E9-9378-9E22C26C23A2	Primary Tumor	Illumina HiSeq	35b27702-57f1-4e49-8d49-3efa49e48c34	Uterus	60	4C657AD4-2C53-4EA9-82B5-52996E74E3FF	19C1C97F-A3EC-44A8-8A20-6F97CAED1A4F	TCGA-AP-A0LH-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0LH	TCGA-UCEC	1106	s4969	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Mixed serous and endometrioid	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf731a2	58cfa83ce4b0c9d6adf731a2	a8fa89810891a177c65d943664f1e99b.filtered.	WGS	a8fa89810891a177c65d943664f1e99b	a8fa89810891a177c65d943664f1e99b.bam	106.68	1.91	0.08	58cfa83ce4b0c9d6adf731a2	a8fa89810891a177c65d943664f1e99b.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-DI-A1NN-01A	944A102F-3475-45AA-9E30-4B92D1449F00	Primary Tumor	Illumina HiSeq	b518c962-e072-40bd-962b-f0eebac9aa3b	Uterus	63	5FABCE9C-0DFB-4B0D-8478-599FD181A84F	95E8D38A-122E-494C-A304-BEF4275FED7E	TCGA-DI-A1NN-01A-11D-A34H-09	GRCh37-lite	TCGA-DI-A1NN	TCGA-UCEC	NA	s4760	Washington University School of Medicine	MD Anderson	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A34H-09	TRUE
13722.58cfa83ce4b0c9d6adf73168	58cfa83ce4b0c9d6adf73168	f31cfe2ad0117626a14c5b0dea28c02d.filtered.	WGS	f31cfe2ad0117626a14c5b0dea28c02d	f31cfe2ad0117626a14c5b0dea28c02d.bam	91.48	2.08	0.08	58cfa83ce4b0c9d6adf73168	f31cfe2ad0117626a14c5b0dea28c02d.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LF-01A	748E38B1-2EAD-4A0A-8881-D640617B856B	Primary Tumor	Illumina HiSeq	edd786b0-5020-470f-a33f-28c99bef68c0	Uterus	82	902E2DD8-81E5-4949-A57B-92B3EFD86C63	460F7427-EBCF-404B-9E9E-E0278D0BCA95	TCGA-AP-A0LF-01A-11D-A122-09	GRCh37-lite	TCGA-AP-A0LF	TCGA-UCEC	NA	s5374	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A122-09	TRUE
13722.58cfa83ce4b0c9d6adf73074	58cfa83ce4b0c9d6adf73074	f69f0ef802b7feefa79f55fe3e188902.filtered.	WGS	f69f0ef802b7feefa79f55fe3e188902	f69f0ef802b7feefa79f55fe3e188902.bam	35.42	1.97	0.08	58cfa83ce4b0c9d6adf73074	f69f0ef802b7feefa79f55fe3e188902.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A12Q-01A	A824B3BD-34D5-4CC1-A92F-F9D6AC0F1814	Primary Tumor	Illumina HiSeq	bb80680a-245c-421b-a3ef-198dc78bad1e	Breast	78	8867F07E-0993-4C9A-96DF-18E24801BA80	D8C6D4B8-F279-4EDC-AAA3-A1CC266AEC4D	TCGA-C8-A12Q-01A-11D-A19H-09	GRCh37-lite	TCGA-C8-A12Q	TCGA-BRCA	NA	s6108	Washington University School of Medicine	ILSbio	None	NO	T1	N2	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf7310e	58cfa83ce4b0c9d6adf7310e	c31801ffe0265e1332d28d053c9a4955.filtered.	WGS	c31801ffe0265e1332d28d053c9a4955	c31801ffe0265e1332d28d053c9a4955.bam	64.37	1.97	0.08	58cfa83ce4b0c9d6adf7310e	c31801ffe0265e1332d28d053c9a4955.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A12L-01A	441919EB-8C9F-478C-BDA3-8DE4F8295E8A	Primary Tumor	Illumina HiSeq	c12fbad8-2c66-4967-9bfe-6837f6d1e5d4	Breast	67	E3CF8F8C-8FE6-45E2-B786-7DB5590C08CB	D5372745-95CF-4572-A6E7-E7F5B796911A	TCGA-C8-A12L-01A-11D-A19H-09	GRCh37-lite	TCGA-C8-A12L	TCGA-BRCA	NA	s5945	Washington University School of Medicine	ILSbio	Vietnam	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf72f75	58cfa83ce4b0c9d6adf72f75	f059a2333e0663ef4831e98db4f4c9e5.filtered.	WGS	f059a2333e0663ef4831e98db4f4c9e5	f059a2333e0663ef4831e98db4f4c9e5.bam	69.64	1.86	0.08	58cfa83ce4b0c9d6adf72f75	f059a2333e0663ef4831e98db4f4c9e5.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A08B-01A	D8D7A6C2-6427-4F47-968C-6C3AFFBA4617	Primary Tumor	Illumina HiSeq	f0967810-7b67-40b6-9995-a392153f2fba	Breast	52	1964ADDF-C524-4C72-B596-009235BAD133	F6114C69-71A1-47D5-9B28-B0227B1872F7	TCGA-A8-A08B-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A08B	TCGA-BRCA	NA	s6447	Washington University School of Medicine	Indivumed	Germany	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a44c	58cfa82de4b0c9d6adf6a44c	023c722ed278d2ab1cbbeef1bfee4130.filtered.	WGS	023c722ed278d2ab1cbbeef1bfee4130	023c722ed278d2ab1cbbeef1bfee4130.bam	45.87	1.86	0.08	58cfa82de4b0c9d6adf6a44c	023c722ed278d2ab1cbbeef1bfee4130.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E9-A1NH-01A	B2AAC45B-2073-4C7A-ADB9-769A4FDCC111	Primary Tumor	Illumina HiSeq	f57cf947-b314-4a64-a112-d09cc8045594	Breast	71	FB0B2D84-D982-4D3A-9803-36420F2E7E46	13C312EC-0ADD-4758-AB8D-C193E2E08C6D	TCGA-E9-A1NH-01A-11D-A14G-09	GRCh37-lite	TCGA-E9-A1NH	TCGA-BRCA	NA	s6449	Washington University School of Medicine	Asterand	Russia	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB	A14G-09	FALSE
13722.58cfa82de4b0c9d6adf6a49a	58cfa82de4b0c9d6adf6a49a	1d2f2091a246a644d3f997d0edfd860a.filtered.	WGS	1d2f2091a246a644d3f997d0edfd860a	1d2f2091a246a644d3f997d0edfd860a.bam	17.4	1.97	0.08	58cfa82de4b0c9d6adf6a49a	1d2f2091a246a644d3f997d0edfd860a.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0EY-01A	D67CD793-2931-429A-9084-2F3C4C8BE7AD	Primary Tumor	Illumina HiSeq	79cc669f-41ce-4384-ac00-fe94ad0c8cd5	Breast	62	2A3E4DBB-AAFF-4B14-BBED-F2D7CF0F8FA3	01658141-8398-4585-9F0F-8355DD9B0604	TCGA-A2-A0EY-01A-11D-A19H-09	GRCh37-lite	TCGA-A2-A0EY	TCGA-BRCA	NA	s5947	Washington University School of Medicine	Walter Reed	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a4be	58cfa82de4b0c9d6adf6a4be	16c5b03f7a162662f87a6ef4eb8efdb7.filtered.	WGS	16c5b03f7a162662f87a6ef4eb8efdb7	16c5b03f7a162662f87a6ef4eb8efdb7.bam	78.05	1.93	0.08	58cfa82de4b0c9d6adf6a4be	16c5b03f7a162662f87a6ef4eb8efdb7.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A05D-01A	F7E06A10-74CA-4F52-A944-B3F22C016998	Primary Tumor	Illumina HiSeq	4cb18a3e-36df-43cb-ab17-5ba82f2a7949	Uterus	67	5B19AF28-1179-42CB-A474-856EF2048D5B	82D2EA5F-EBDC-4907-A287-FE837FD6B59C	TCGA-AP-A05D-01A-11D-A013-09	GRCh37-lite	TCGA-AP-A05D	TCGA-UCEC	NA	s4981	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa82de4b0c9d6adf6a47a	58cfa82de4b0c9d6adf6a47a	36b47238be0497f388623d943762497c.filtered.	WGS	36b47238be0497f388623d943762497c	36b47238be0497f388623d943762497c.bam	64.57	NA	0.08	58cfa82de4b0c9d6adf6a47a	36b47238be0497f388623d943762497c.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2R9-01A	00AD0FFE-2105-4829-A495-1C2ACEB5BB31	Primary Tumor	Illumina HiSeq	d25f9f12-7f03-4bbe-befe-f9250955975c	Cervix	58	7EFD873D-8165-40F8-A07D-69CFD68A491E	9FF21093-58D7-4B69-AADE-C242A383EA56	TCGA-EK-A2R9-01A-11D-A34H-09	GRCh37-lite	TCGA-EK-A2R9	TCGA-CESC	NA	s1347	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma	Not available	A34H-09	TRUE
13722.58cfa82de4b0c9d6adf6a4e6	58cfa82de4b0c9d6adf6a4e6	114daee2d5db94a8d315a300daafb728.filtered.	WGS	114daee2d5db94a8d315a300daafb728	114daee2d5db94a8d315a300daafb728.bam	20.16	NA	0.08	58cfa82de4b0c9d6adf6a4e6	114daee2d5db94a8d315a300daafb728.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3U5-01A	8F3F6F7C-4B50-467E-A6E8-D836735913F6	Primary Tumor	Illumina HiSeq	bee06413-ec4c-4545-b54d-d858d6a6e6e3	Mesenchymal	52	FB5C61D6-717E-4798-8306-86EB196D5609	3C963890-6E79-4B16-A4AA-BAC04938B4D7	TCGA-DX-A3U5-01A-11D-A228-09	GRCh37-lite	TCGA-DX-A3U5	TCGA-SARC	NA	s2473	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A228-09	FALSE
13722.58cfa82de4b0c9d6adf6a518	58cfa82de4b0c9d6adf6a518	143a9f78e15769fd3d037c291de40599.filtered.	WGS	143a9f78e15769fd3d037c291de40599	143a9f78e15769fd3d037c291de40599.bam	85.82	2.12	0.07	58cfa82de4b0c9d6adf6a518	143a9f78e15769fd3d037c291de40599.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K3-01A	79ECC142-8F6E-4260-A7CE-C8E2A6212C35	Primary Tumor	Illumina HiSeq	b48383ea-36f6-4edd-ae2e-04b235d472a3	Uterus	62	ED31DDC2-FEDA-496E-A642-0C4B5DCE014D	D12CFD8B-682D-41DF-ACF8-EE7F68A6241C	TCGA-B5-A0K3-01A-11D-A325-09	GRCh37-lite	TCGA-B5-A0K3	TCGA-UCEC	NA	s5375	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A325-09	TRUE
13722.58cfa82de4b0c9d6adf6a514	58cfa82de4b0c9d6adf6a514	39d36a4631a0662e48415735c9e225a7.filtered.	WGS	39d36a4631a0662e48415735c9e225a7	39d36a4631a0662e48415735c9e225a7.bam	41.18	2.26	0.09	58cfa82de4b0c9d6adf6a514	39d36a4631a0662e48415735c9e225a7.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A1MY-01A	5D2F1A0F-A01B-48C2-B749-1CA710AA2BB4	Primary Tumor	Illumina HiSeq	d76a05f0-61cd-42ac-9cbe-0c1fe2a9a85e	Uterus	62	26189CF5-AE49-44CF-842B-35A3063AB93C	493E7008-551C-4C0E-B567-A0F31868629E	TCGA-B5-A1MY-01A-11D-A142-09	GRCh37-lite	TCGA-B5-A1MY	TCGA-UCEC	361	s4766	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A142-09	FALSE
13722.58cfa82de4b0c9d6adf6a522	58cfa82de4b0c9d6adf6a522	2e173cba9eef7aec792a9b66d36c62fd.filtered.	WGS	2e173cba9eef7aec792a9b66d36c62fd	2e173cba9eef7aec792a9b66d36c62fd.bam	107.95	1.77	0.09	58cfa82de4b0c9d6adf6a522	2e173cba9eef7aec792a9b66d36c62fd.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1FC-01A	B97BF89A-7A85-4EEF-AE7E-F787AEAD1F0A	Primary Tumor	Illumina HiSeq	96f6b8e2-d4c6-44db-a8d4-3c7549e04038	Breast	78	3AD0093A-E57A-450A-B0EF-942C9B67A586	84C77098-03D0-4B22-AFB1-797703E85C6C	TCGA-BH-A1FC-01A-11D-A13L-09	GRCh37-lite	TCGA-BH-A1FC	TCGA-BRCA	3472	s6455	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1b	Medullary Carcinoma	Stage IIA	A13L-09	FALSE
13722.58cfa82de4b0c9d6adf6a51c	58cfa82de4b0c9d6adf6a51c	3016434d8255a1fb2b32ae1ae47ef1ec.filtered.	WGS	3016434d8255a1fb2b32ae1ae47ef1ec	3016434d8255a1fb2b32ae1ae47ef1ec.bam	57.13	1.93	0.08	58cfa82de4b0c9d6adf6a51c	3016434d8255a1fb2b32ae1ae47ef1ec.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A18U-01A	233B02F3-C4F0-4A67-9DB5-E68D5CDACCB6	Primary Tumor	Illumina HiSeq	8797ff7d-3b2a-4ac8-b8a3-375982e8413e	Breast	72	79763193-268D-49E7-B94C-5CB95F7271B6	FB9135D9-2ACF-41DD-8552-359E6B8C9470	TCGA-BH-A18U-01A-21D-A19H-09	GRCh37-lite	TCGA-BH-A18U	TCGA-BRCA	1563	s6912	Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a535	58cfa82de4b0c9d6adf6a535	4d34550076e0e5e5f628e1f2d531963f.filtered.	WGS	4d34550076e0e5e5f628e1f2d531963f	4d34550076e0e5e5f628e1f2d531963f.bam	58.16	2	0.07	58cfa82de4b0c9d6adf6a535	4d34550076e0e5e5f628e1f2d531963f.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D4-01A	75113445-D2D6-44A0-866C-C9175E6D214B	Primary Tumor	Illumina HiSeq	ac8422e5-dfeb-40c6-ab1f-dddd9f7fb015	Breast	37	ACE39EF3-1B5E-4AD2-A20D-62957E524281	2B000AF3-2C9D-4EAA-AF3F-8101B7425C37	TCGA-A2-A0D4-01A-11D-A314-09	GRCh37-lite	TCGA-A2-A0D4	TCGA-BRCA	NA	s6624	Washington University School of Medicine	Walter Reed	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a53a	58cfa82de4b0c9d6adf6a53a	55d6e765b492c11513427738173a07b8.filtered.	WGS	55d6e765b492c11513427738173a07b8	55d6e765b492c11513427738173a07b8.bam	8.07	NA	0.08	58cfa82de4b0c9d6adf6a53a	55d6e765b492c11513427738173a07b8.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-FX-A3RE-01A	7F9031DA-124A-4A38-83E6-878A50E58C24	Primary Tumor	Illumina HiSeq	41901beb-8e75-49c2-8bc3-a73dcaff36b1	Mesenchymal	65	8FAEDD92-D7FA-452A-8210-741118E516F7	CDBBD701-9C05-4F9E-923D-06039DD8A04D	TCGA-FX-A3RE-01A-11D-A228-09	GRCh37-lite	TCGA-FX-A3RE	TCGA-SARC	NA	s2336	Washington University School of Medicine	International Genomics Consortium	United States	NO	Not available	Not available	Not available	Not available	A228-09	FALSE
13722.58cfa82de4b0c9d6adf6a570	58cfa82de4b0c9d6adf6a570	2d3ccd84c9564a9f00feb1379762746c.filtered.	WGS	2d3ccd84c9564a9f00feb1379762746c	2d3ccd84c9564a9f00feb1379762746c.bam	78.11	1.95	0.08	58cfa82de4b0c9d6adf6a570	2d3ccd84c9564a9f00feb1379762746c.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A2H5-01A	C88E3901-F3EE-436A-BA80-143C8EAB7D69	Primary Tumor	Illumina HiSeq	6b01cf12-3537-4e5e-857f-de5dd14c85ce	Uterus	67	44EB96B4-5E4F-460B-BC51-ADD38CBC76A1	CC19A480-9C66-4EE8-A0C0-921ACAC02689	TCGA-AX-A2H5-01A-11D-A34H-09	GRCh37-lite	TCGA-AX-A2H5	TCGA-UCEC	NA	s5376	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A34H-09	TRUE
13722.58cfa82de4b0c9d6adf6a4e2	58cfa82de4b0c9d6adf6a4e2	3868e1400ab74a5d31b7f3ace5862177.filtered.	WGS	3868e1400ab74a5d31b7f3ace5862177	3868e1400ab74a5d31b7f3ace5862177.bam	31.37	NA	0.08	58cfa82de4b0c9d6adf6a4e2	3868e1400ab74a5d31b7f3ace5862177.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RE-01A	9AA36AC2-8418-4109-A3C1-63CA8742BAAB	Primary Tumor	Illumina HiSeq	87fe03fa-225c-4d35-81a3-8b401d985fae	Cervix	26	7BCF54B6-3FFA-4014-92C6-51A7099E6F02	0D31A44F-1FC5-43A2-9633-36C4E650D3D2	TCGA-EK-A2RE-01A-11D-A34H-09	GRCh37-lite	TCGA-EK-A2RE	TCGA-CESC	NA	s1162	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	T2a2	N0	Cervical Squamous Cell Carcinoma	Not available	A34H-09	TRUE
13722.58cfa82de4b0c9d6adf6a599	58cfa82de4b0c9d6adf6a599	6520482bf50a726c446002cb9b06ac69.filtered.	WGS	6520482bf50a726c446002cb9b06ac69	6520482bf50a726c446002cb9b06ac69.bam	27.61	NA	0.08	58cfa82de4b0c9d6adf6a599	6520482bf50a726c446002cb9b06ac69.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IE-A4EI-01A	C5E23947-253B-40D2-916A-277B2A580BE2	Primary Tumor	Illumina HiSeq	6070f836-ad03-4454-9395-d7c38f0949c9	Mesenchymal	67	1FE30A2F-22A6-4F88-9A3A-7A11359CC151	522DC834-8367-4F49-B93B-FCBA91A2DE7E	TCGA-IE-A4EI-01A-11D-A24N-09	GRCh37-lite	TCGA-IE-A4EI	TCGA-SARC	NA	s2339	Washington University School of Medicine	ABS - IUPUI	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa82de4b0c9d6adf6a58f	58cfa82de4b0c9d6adf6a58f	5ef6a0389326d4bf5accd20037a358d3.filtered.	WGS	5ef6a0389326d4bf5accd20037a358d3	5ef6a0389326d4bf5accd20037a358d3.bam	42.25	2	0.08	58cfa82de4b0c9d6adf6a58f	5ef6a0389326d4bf5accd20037a358d3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AQ-A04J-01A	9938CE5C-E74E-446E-A932-F096F85CC3B1	Primary Tumor	Illumina HiSeq	c57fe789-7ef3-4dcb-bc21-b7ccb5ff208e	Breast	45	09D6F42C-5E9F-4ADC-BD8C-E5DCA597FC01	467EF778-F481-44F3-9768-B9900252D2BA	TCGA-AQ-A04J-01A-02D-A128-09	GRCh37-lite	TCGA-AQ-A04J	TCGA-BRCA	NA	s6115	Washington University School of Medicine	Not available	United States	NO	T2	N0 (i+)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa82de4b0c9d6adf6a5b3	58cfa82de4b0c9d6adf6a5b3	551a836dfba4ddbf7b7859a2395b7794.filtered.	WGS	551a836dfba4ddbf7b7859a2395b7794	551a836dfba4ddbf7b7859a2395b7794.bam	30.4	NA	0.09	58cfa82de4b0c9d6adf6a5b3	551a836dfba4ddbf7b7859a2395b7794.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3M1-01A	B85E2156-D5AC-486C-93E1-86525EA41A64	Primary Tumor	Illumina HiSeq	bb1d2bd3-0664-4d25-a029-9fe225b91c2e	Mesenchymal	79	1AFCDB32-AE26-4747-A131-54E83DD84A46	72F0A49A-AEC8-47E5-846A-956C4DA1507C	TCGA-DX-A3M1-01A-11D-A228-09	GRCh37-lite	TCGA-DX-A3M1	TCGA-SARC	NA	s2338	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A228-09	FALSE
13722.58cfa82de4b0c9d6adf6a5b2	58cfa82de4b0c9d6adf6a5b2	6822184f0a41bd067261cf1591f0dbf6.filtered.	WGS	6822184f0a41bd067261cf1591f0dbf6	6822184f0a41bd067261cf1591f0dbf6.bam	34.66	1.95	0.08	58cfa82de4b0c9d6adf6a5b2	6822184f0a41bd067261cf1591f0dbf6.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A12H-01A	B5B99291-507E-4B68-A039-9A0F571F55DF	Primary Tumor	Illumina HiSeq	55b85b3a-3eed-4a89-ab63-56b85e180571	Breast	69	D8AFCB32-81D0-43B3-AD5C-E8C735710624	5A535C49-D42E-43C6-9D32-DC76F28D4F0F	TCGA-AO-A12H-01A-11D-A10Y-09	GRCh37-lite	TCGA-AO-A12H	TCGA-BRCA	NA	s5481	Washington University School of Medicine	MSKCC	None	NO	T2	N0 (i-)	Other  specify	Stage IIA	A10Y-09	FALSE
13722.58cfa82de4b0c9d6adf6a5ce	58cfa82de4b0c9d6adf6a5ce	730dac4f2b9e3f7bc83f758dbd514583.filtered.	WGS	730dac4f2b9e3f7bc83f758dbd514583	730dac4f2b9e3f7bc83f758dbd514583.bam	59.62	2.13	0.08	58cfa82de4b0c9d6adf6a5ce	730dac4f2b9e3f7bc83f758dbd514583.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GG-01A	A8614C49-C7F1-4DE9-BD2F-4764B094D604	Primary Tumor	Illumina HiSeq	c4002956-bdc1-4b16-810a-ccf4b006d29b	Uterus	76	B5B941E3-F828-4091-B9B1-6B38D1493847	F7187888-F261-4A39-99B4-966FD7207117	TCGA-A5-A0GG-01A-11D-A122-09	GRCh37-lite	TCGA-A5-A0GG	TCGA-UCEC	NA	s5379	Washington University School of Medicine	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A122-09	TRUE
13722.58cfa82de4b0c9d6adf6a618	58cfa82de4b0c9d6adf6a618	5c56d50bef568c9257651f615ec606b3.filtered.	WGS	5c56d50bef568c9257651f615ec606b3	5c56d50bef568c9257651f615ec606b3.bam	70.96	1.93	0.08	58cfa82de4b0c9d6adf6a618	5c56d50bef568c9257651f615ec606b3.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PH-01A	4DA999A0-EF41-4A0B-B1D1-446B39CC855A	Primary Tumor	Illumina HiSeq	877bbc2d-444f-44cf-8e0f-3fd2744c3f91	Breast	52	DD38BA60-656A-46F7-B22B-BCEE3B6D2F19	DF291849-4C35-44E1-B013-8F6B7EE36113	TCGA-EW-A1PH-01A-11D-A17G-09	GRCh37-lite	TCGA-EW-A1PH	TCGA-BRCA	NA	s5951	Washington University School of Medicine	University of Miami	United States	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A17G-09	FALSE
13722.58cfa82de4b0c9d6adf6a60c	58cfa82de4b0c9d6adf6a60c	749ef764c5fcf5ac98cf3e0086566a41.filtered.	WGS	749ef764c5fcf5ac98cf3e0086566a41	749ef764c5fcf5ac98cf3e0086566a41.bam	7.51	NA	0.08	58cfa82de4b0c9d6adf6a60c	749ef764c5fcf5ac98cf3e0086566a41.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A1L3-01A	9517413B-B5B8-4130-8BA1-D86D44ABE2EC	Primary Tumor	Illumina HiSeq	f5fa948e-2119-4b86-8bc3-7ef737ffdffe	Mesenchymal	60	19A45767-ABF7-4D53-B096-B59847FC47A8	18EC066E-8510-4921-9E35-45D85FB01E38	TCGA-DX-A1L3-01A-11D-A24N-09	GRCh37-lite	TCGA-DX-A1L3	TCGA-SARC	NA	s2347	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa82de4b0c9d6adf6a61e	58cfa82de4b0c9d6adf6a61e	67919d6ae2817354d43a764971e0608f.filtered.	WGS	67919d6ae2817354d43a764971e0608f	67919d6ae2817354d43a764971e0608f.bam	59.44	1.73	0.08	58cfa82de4b0c9d6adf6a61e	67919d6ae2817354d43a764971e0608f.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1BN-01B	8A4DA4F0-30F2-497E-8A7C-988FD6B813CB	Primary Tumor	Illumina HiSeq	df3a48da-646a-4834-969a-131455b7baa9	Cervix	26	DD05713E-6D6D-4876-89DF-69A905D24500	06DAD93A-4B67-49B3-8FA5-F2546E22BAE7	TCGA-C5-A1BN-01B-11D-A200-09	GRCh37-lite	TCGA-C5-A1BN	TCGA-CESC	166	s1510	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a65e	58cfa82de4b0c9d6adf6a65e	6dfdd72436bacf6a5f435146137eee03.filtered.	WGS	6dfdd72436bacf6a5f435146137eee03	6dfdd72436bacf6a5f435146137eee03.bam	8.01	NA	0.08	58cfa82de4b0c9d6adf6a65e	6dfdd72436bacf6a5f435146137eee03.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A2J4-01A	F75D2589-FD7B-49A1-A1C8-0B4726B81F3C	Primary Tumor	Illumina HiSeq	ffc58c6a-5a11-4c5f-a5dd-b5082be0dc38	Mesenchymal	60	46E59502-D5DF-428B-BEEF-6AD1439B86C6	968929B0-6BFB-4A2C-BD4D-570BFCDB8A6A	TCGA-DX-A2J4-01A-32D-A21Q-09	GRCh37-lite	TCGA-DX-A2J4	TCGA-SARC	NA	s2340	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a640	58cfa82de4b0c9d6adf6a640	7a02be700709d5daf6393100f819a952.filtered.	WGS	7a02be700709d5daf6393100f819a952	7a02be700709d5daf6393100f819a952.bam	51.59	NA	0.08	58cfa82de4b0c9d6adf6a640	7a02be700709d5daf6393100f819a952.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A2J0-01A	2FF6AEDE-7BCD-440B-99AB-7A023FAF658E	Primary Tumor	Illumina HiSeq	99a5bf7b-7b43-4753-ac23-1a777776a1dc	Mesenchymal	61	A8673BA9-EF34-42CA-A73E-1EFB4F186E88	CB783F8B-D092-4104-B809-3F90B19DF7DF	TCGA-DX-A2J0-01A-11D-A21Q-09	GRCh37-lite	TCGA-DX-A2J0	TCGA-SARC	295	s2346	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a674	58cfa82de4b0c9d6adf6a674	4e9520d4069328bdb2c43937716bc859.filtered.	WGS	4e9520d4069328bdb2c43937716bc859	4e9520d4069328bdb2c43937716bc859.bam	27.88	NA	0.08	58cfa82de4b0c9d6adf6a674	4e9520d4069328bdb2c43937716bc859.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3U7-01A	EA3A524B-6EE3-4904-8924-29FCAA20985C	Primary Tumor	Illumina HiSeq	0c2d7c45-b582-429b-bf9f-ed279421c8a6	Mesenchymal	67	910CD9B0-5BBE-47E5-8F4C-A6E8AA580281	9E7B51FB-2249-451A-BF23-BB2A3D935928	TCGA-DX-A3U7-01A-11D-A29N-09	GRCh37-lite	TCGA-DX-A3U7	TCGA-SARC	NA	s2487	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A29N-09	FALSE
13722.58cfa82de4b0c9d6adf6a68a	58cfa82de4b0c9d6adf6a68a	92b17b06dd8c1279647435d6dc17b382.filtered.	WGS	92b17b06dd8c1279647435d6dc17b382	92b17b06dd8c1279647435d6dc17b382.bam	23.61	1.87	0.07	58cfa82de4b0c9d6adf6a68a	92b17b06dd8c1279647435d6dc17b382.bam	Dead	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A09X-01A	27B05B15-A44B-45ED-A6E3-E7D1CA488EA9	Primary Tumor	Illumina HiSeq	8327f8db-6932-4661-a116-5909cd8e4c81	Breast	62	5A9087B1-D001-4FCC-B061-F59E7026E711	6DBC5C31-043B-40E9-BF1A-E7B4EC351B4D	TCGA-A8-A09X-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A09X	TCGA-BRCA	426	s5633	Washington University School of Medicine	Indivumed	Germany	NO	T2	N3a	Infiltrating Lobular Carcinoma	Stage IIIC	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a65f	58cfa82de4b0c9d6adf6a65f	5b233e3c073c9b60910bddaec0e5ed79.filtered.	WGS	5b233e3c073c9b60910bddaec0e5ed79	5b233e3c073c9b60910bddaec0e5ed79.bam	71.04	2	0.07	58cfa82de4b0c9d6adf6a65f	5b233e3c073c9b60910bddaec0e5ed79.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A11G-01A	D2AA7D70-A25F-4A9E-9D52-37E372461824	Primary Tumor	Illumina HiSeq	bef94a7d-d7f5-4172-9a0c-5b3dc033ca00	Uterus	71	FE5D8E64-98B1-4EA7-ADDA-F28D12349A7E	42DE1441-6F3C-4B4D-B8B8-AD91E4B1DBE2	TCGA-B5-A11G-01A-13D-A122-09	GRCh37-lite	TCGA-B5-A11G	TCGA-UCEC	NA	s4411	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A122-09	TRUE
13722.58cfa82de4b0c9d6adf6a6d4	58cfa82de4b0c9d6adf6a6d4	84cabc6d988c220d0be27b3d2d76db69.filtered.	WGS	84cabc6d988c220d0be27b3d2d76db69	84cabc6d988c220d0be27b3d2d76db69.bam	17.19	NA	0.08	58cfa82de4b0c9d6adf6a6d4	84cabc6d988c220d0be27b3d2d76db69.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IE-A4EK-01A	590FDB76-20EF-4F95-9783-7D80E7A25E5A	Primary Tumor	Illumina HiSeq	01fcfdba-18c9-4abf-84be-b5fbac48d25a	Mesenchymal	54	9963DA13-6EA7-48A3-A3DE-1C6A38F977B9	56681386-D407-4F53-AE4F-6C04437652F7	TCGA-IE-A4EK-01A-11D-A24N-09	GRCh37-lite	TCGA-IE-A4EK	TCGA-SARC	NA	s2494	Washington University School of Medicine	ABS - IUPUI	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa82de4b0c9d6adf6a6da	58cfa82de4b0c9d6adf6a6da	917393fd54d541ee5bf939911e9e1142.filtered.	WGS	917393fd54d541ee5bf939911e9e1142	917393fd54d541ee5bf939911e9e1142.bam	17.01	NA	0.08	58cfa82de4b0c9d6adf6a6da	917393fd54d541ee5bf939911e9e1142.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-MO-A47R-01A	8654C2B5-27D7-43C5-9A39-7FDEFD7A0324	Primary Tumor	Illumina HiSeq	1e530776-868a-4b43-ac6b-7e692691b675	Mesenchymal	75	3D38F7C9-00DD-47C1-8649-C50574953AAB	7A5D3B6B-BE5A-4E55-9255-32A069B8AF3D	TCGA-MO-A47R-01A-11D-A24N-09	GRCh37-lite	TCGA-MO-A47R	TCGA-SARC	NA	s2492	Washington University School of Medicine	ILSbio	Vietnam	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa830e4b0c9d6adf6bb98	58cfa830e4b0c9d6adf6bb98	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	66.88	1.91	0.08	58cfa830e4b0c9d6adf6bb98	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D0-01A	324BCBA2-F6A4-45A6-807C-215BDFFCCA21	Primary Tumor	Illumina HiSeq	25ddf041-bc97-4ced-aa1a-cf0339d8c23b	Breast	60	7FD5702E-2D7B-4B79-B2D8-5CA4CA33CF65	71FDA5A9-7049-406F-9348-2C24F7DDF5F4	TCGA-A2-A0D0-01A-11D-A128-09	GRCh37-lite	TCGA-A2-A0D0	TCGA-BRCA	NA	s6270	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6bdea	58cfa830e4b0c9d6adf6bdea	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	73.41	1.97	0.07	58cfa830e4b0c9d6adf6bdea	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0B9-01A	5A57DC25-D252-4B22-B192-4DE630D7002F	Primary Tumor	Illumina HiSeq	1a49cb56-547c-4a77-84e6-116bc406ba19	Breast	44	8137FFEE-BB4F-4E5F-B831-ACFC9C5585A8	CF599959-6AAF-48EA-8A15-8EF09163BAD7	TCGA-BH-A0B9-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0B9	TCGA-BRCA	NA	s6770	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf72ea0	58cfa83ce4b0c9d6adf72ea0	cab14fc1d7b56274f68e25c36ca1fe72.filtered.	WGS	cab14fc1d7b56274f68e25c36ca1fe72	cab14fc1d7b56274f68e25c36ca1fe72.bam	117.13	2.03	0.08	58cfa83ce4b0c9d6adf72ea0	cab14fc1d7b56274f68e25c36ca1fe72.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A054-01A	D77E4DBC-B239-4742-8CB7-EFD427010D13	Primary Tumor	Illumina HiSeq	ac0e9eff-9bcd-4c94-a329-d07bcc7d5620	Uterus	64	DDFFB9C7-185F-402F-99B8-8058B40086D9	7364A112-61B9-41C6-B85F-18C97C54CEFD	TCGA-AP-A054-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A054	TCGA-UCEC	709	s5371	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf72eb0	58cfa83ce4b0c9d6adf72eb0	cea4bc4275e349522246f3666f7965b5.filtered.	WGS	cea4bc4275e349522246f3666f7965b5	cea4bc4275e349522246f3666f7965b5.bam	46.1	1.75	0.09	58cfa83ce4b0c9d6adf72eb0	cea4bc4275e349522246f3666f7965b5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A27F-01A	1549DC64-3DAB-43FC-96E9-B07D520957E1	Primary Tumor	Illumina HiSeq	f4f2c07e-84b7-47d0-88fe-7032564a1ecc	Breast	40	7E9145F7-CCFF-4132-B2B7-9B992EEBEBF4	FC6D77A9-121B-48AB-A899-713C3D1319A2	TCGA-D8-A27F-01A-11D-A16D-09	GRCh37-lite	TCGA-D8-A27F	TCGA-BRCA	NA	s6967	Washington University School of Medicine	Greater Poland Cancer Center	Poland	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A16D-09	FALSE
13722.58cfa83ce4b0c9d6adf72edb	58cfa83ce4b0c9d6adf72edb	df4a0a1fa966f237f85dc788514a4f3f.filtered.	WGS	df4a0a1fa966f237f85dc788514a4f3f	df4a0a1fa966f237f85dc788514a4f3f.bam	18.8	NA	0.08	58cfa83ce4b0c9d6adf72edb	df4a0a1fa966f237f85dc788514a4f3f.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A3U0-01A	D9DC3B59-613D-469E-8B4F-6C5A557EB26A	Primary Tumor	Illumina HiSeq	107557e5-5611-4f30-9544-e8c315cb063d	Breast	61	549F03A5-3F91-4975-9EEB-AA062264A602	0448206F-3ADE-4087-B1A9-4FB2D14E1367	TCGA-EW-A3U0-01A-11D-A228-09	GRCh37-lite	TCGA-EW-A3U0	TCGA-BRCA	NA	s6610	Washington University School of Medicine	University of Miami	United States	NO	T3	N1a	Infiltrating Ductal Carcinoma	Stage IIIA	A228-09	FALSE
13722.58cfa83ce4b0c9d6adf72ed8	58cfa83ce4b0c9d6adf72ed8	e56f2db4726f327debd64334f96bcd04.filtered.	WGS	e56f2db4726f327debd64334f96bcd04	e56f2db4726f327debd64334f96bcd04.bam	45.06	NA	0.08	58cfa83ce4b0c9d6adf72ed8	e56f2db4726f327debd64334f96bcd04.bam	Dead	FEMALE	WHITE	Not available	Sarcoma	Aligned reads	TCGA-IW-A3M5-01A	C20682A1-F340-430D-99F9-077FE093ED19	Primary Tumor	Illumina HiSeq	83802f59-1279-444a-b96b-4bbdf0aa3baa	Mesenchymal	76	34B60937-76B3-401C-A8DD-3F78E2B20A38	03CED0CE-186A-4349-8D98-572C2BC90382	TCGA-IW-A3M5-01A-22D-A21Q-09	GRCh37-lite	TCGA-IW-A3M5	TCGA-SARC	180	s2671	Washington University School of Medicine	Cedars Sinai	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf72ef4	58cfa83ce4b0c9d6adf72ef4	adc8fcb8e8a780076e27704767013d83.filtered.	WGS	adc8fcb8e8a780076e27704767013d83	adc8fcb8e8a780076e27704767013d83.bam	15.93	NA	0.08	58cfa83ce4b0c9d6adf72ef4	adc8fcb8e8a780076e27704767013d83.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A240-01A	3608BFBB-2A92-4EC2-A330-BF4790A8B65C	Primary Tumor	Illumina HiSeq	d31b896e-0c05-4b82-9143-a039f927b80f	Mesenchymal	51	8ACAF190-5A0D-440C-9C9A-B9EABDF661BE	3DB6E6CC-1A06-49B9-834E-B6611CDE4C4B	TCGA-DX-A240-01A-32D-A27P-09	GRCh37-lite	TCGA-DX-A240	TCGA-SARC	NA	s2670	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A27P-09	FALSE
13722.58cfa83ce4b0c9d6adf72f0d	58cfa83ce4b0c9d6adf72f0d	b1b5f931c81fbd7859691665e3448ee8.filtered.	WGS	b1b5f931c81fbd7859691665e3448ee8	b1b5f931c81fbd7859691665e3448ee8.bam	7.27	NA	0.08	58cfa83ce4b0c9d6adf72f0d	b1b5f931c81fbd7859691665e3448ee8.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A1L0-01A	854E42BC-95B2-4B77-A4B2-FFBD6C28B281	Primary Tumor	Illumina HiSeq	f7205545-f757-4561-b291-cfe76e7014de	Mesenchymal	58	87E0C11A-CF75-4877-B4C8-23AA36631B4F	1C188BF5-2C99-4EB4-A774-59C75D53E643	TCGA-DX-A1L0-01A-11D-A24N-09	GRCh37-lite	TCGA-DX-A1L0	TCGA-SARC	564	s2461	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72f45	58cfa83ce4b0c9d6adf72f45	e731bc4a6b242f2c3e68d238e90047f3.filtered.	WGS	e731bc4a6b242f2c3e68d238e90047f3	e731bc4a6b242f2c3e68d238e90047f3.bam	50.54	1.82	0.08	58cfa83ce4b0c9d6adf72f45	e731bc4a6b242f2c3e68d238e90047f3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A23R-01A	B5F27002-4277-418D-90B0-CC5A2742692E	Primary Tumor	Illumina HiSeq	8611bde3-531a-4ac4-a742-255c5bd80352	Mesenchymal	55	05FC5924-07B1-422E-9D7C-7C0051F72368	35C797FD-CA81-4CEF-B6C4-7E3776F661B3	TCGA-DX-A23R-01A-11D-A26G-09	GRCh37-lite	TCGA-DX-A23R	TCGA-SARC	NA	s2632	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A26G-09	FALSE
13722.58cfa83ce4b0c9d6adf72f2c	58cfa83ce4b0c9d6adf72f2c	e886a9905c6ddb08a07cd12351b2978e.filtered.	WGS	e886a9905c6ddb08a07cd12351b2978e	e886a9905c6ddb08a07cd12351b2978e.bam	6.36	NA	0.07	58cfa83ce4b0c9d6adf72f2c	e886a9905c6ddb08a07cd12351b2978e.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A1L2-01A	73D2E8EF-4E10-416A-845B-F48374E48ECB	Primary Tumor	Illumina HiSeq	f6170f04-5598-4fb8-9027-6176921b624d	Mesenchymal	78	901DFD62-799D-4E40-926E-22A5FD859B5A	4C59FB2D-21B6-4B09-8174-6102DE736E4D	TCGA-DX-A1L2-01A-22D-A24N-09	GRCh37-lite	TCGA-DX-A1L2	TCGA-SARC	NA	s2633	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72f6c	58cfa83ce4b0c9d6adf72f6c	e869d292dcb3ead5c9128b76af2ac4bb.filtered.	WGS	e869d292dcb3ead5c9128b76af2ac4bb	e869d292dcb3ead5c9128b76af2ac4bb.bam	83.48	1.95	0.08	58cfa83ce4b0c9d6adf72f6c	e869d292dcb3ead5c9128b76af2ac4bb.bam	Dead	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A256-01A	D3D545B3-457F-4389-821F-704CB24AFF7F	Primary Tumor	Illumina HiSeq	83a38860-cf50-4344-8dbf-97d4cda96864	Breast	45	87676C70-E2AD-4103-8BC0-3D3C1E40A790	EA43434B-197E-48AC-AE2E-46BC7F3776DE	TCGA-AR-A256-01A-11D-A167-09	GRCh37-lite	TCGA-AR-A256	TCGA-BRCA	2854	s6448	Washington University School of Medicine	Mayo	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A167-09	FALSE
13722.58cfa83ce4b0c9d6adf72f7b	58cfa83ce4b0c9d6adf72f7b	ea3e2e897deb676e1aa5ff1ce3ef39eb.filtered.	WGS	ea3e2e897deb676e1aa5ff1ce3ef39eb	ea3e2e897deb676e1aa5ff1ce3ef39eb.bam	18.52	NA	0.08	58cfa83ce4b0c9d6adf72f7b	ea3e2e897deb676e1aa5ff1ce3ef39eb.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IF-A4AJ-01A	4E8C570C-3CBE-4878-8B2C-B966868DD60D	Primary Tumor	Illumina HiSeq	5773814e-9b28-40f3-9285-0eed8b3ba493	Mesenchymal	80	86AE3E79-5C03-480F-8A5A-35BAC00CB89D	D53C2680-89AC-4F87-A7BA-F4C669546B76	TCGA-IF-A4AJ-01A-11D-A24N-09	GRCh37-lite	TCGA-IF-A4AJ	TCGA-SARC	767	s2634	Washington University School of Medicine	University of Texas MD Anderson Cancer Center	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72f7f	58cfa83ce4b0c9d6adf72f7f	a94a5ada9a0bb0f8ace6de28512984f7.filtered.	WGS	a94a5ada9a0bb0f8ace6de28512984f7	a94a5ada9a0bb0f8ace6de28512984f7.bam	110.87	2.41	0.08	58cfa83ce4b0c9d6adf72f7f	a94a5ada9a0bb0f8ace6de28512984f7.bam	Alive	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0V8-01A	2B76CC9C-C379-43E4-9C3F-56197A3353BE	Primary Tumor	Illumina HiSeq	9fd5dab8-8c05-4a1c-829e-8e86285bc04f	Uterus	68	CF369A2C-D3C3-4FA3-B004-E4269530CEFF	8D4CB709-C95C-4BDC-844B-C0BFA2A3028E	TCGA-BS-A0V8-01A-11D-A122-09	GRCh37-lite	TCGA-BS-A0V8	TCGA-UCEC	NA	s5178	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A122-09	TRUE
13722.58cfa83ce4b0c9d6adf72f9a	58cfa83ce4b0c9d6adf72f9a	a246b48a0a312eda5cafb748151a117b.filtered.	WGS	a246b48a0a312eda5cafb748151a117b	a246b48a0a312eda5cafb748151a117b.bam	74.65	1.93	0.09	58cfa83ce4b0c9d6adf72f9a	a246b48a0a312eda5cafb748151a117b.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A24Z-01A	9FEFBE7C-F66A-4940-843E-285CB7B392C1	Primary Tumor	Illumina HiSeq	1251c29c-8d85-4187-80dd-c459542e3080	Breast	57	5CDD3886-898B-4861-A748-D4164CE14A07	6C65CB6D-8C50-4C7C-BC84-EEEBE09FBE01	TCGA-AR-A24Z-01A-11D-A314-09	GRCh37-lite	TCGA-AR-A24Z	TCGA-BRCA	NA	s5942	Washington University School of Medicine	Mayo	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A314-09	TRUE
13722.58cfa83ce4b0c9d6adf72f73	58cfa83ce4b0c9d6adf72f73	f0f3dfb66995edcb514e1ccebc2c7e4d.filtered.	WGS	f0f3dfb66995edcb514e1ccebc2c7e4d	f0f3dfb66995edcb514e1ccebc2c7e4d.bam	61.2	1.96	0.09	58cfa83ce4b0c9d6adf72f73	f0f3dfb66995edcb514e1ccebc2c7e4d.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A130-01A	8CF54607-01CE-42B0-9BD9-8627EDD9F3B7	Primary Tumor	Illumina HiSeq	e70e14f9-ea63-4038-8a0e-5526391ea4fe	Breast	52	3BEA8456-DA16-4691-A260-5C94A83E2860	27F87D1E-2C32-4BEB-9677-62F7A286673D	TCGA-C8-A130-01A-31D-A19H-09	GRCh37-lite	TCGA-C8-A130	TCGA-BRCA	NA	s6751	Washington University School of Medicine	ILSbio	Vietnam	NO	T3	N2	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf72fb2	58cfa83ce4b0c9d6adf72fb2	a71534313dd3551e1b02d0eed8d54add.filtered.	WGS	a71534313dd3551e1b02d0eed8d54add	a71534313dd3551e1b02d0eed8d54add.bam	55.26	NA	0.08	58cfa83ce4b0c9d6adf72fb2	a71534313dd3551e1b02d0eed8d54add.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A2LK-01A	1B703058-E596-45BC-80FE-8B98D545C2E2	Primary Tumor	Illumina HiSeq	452eb1a3-2221-409b-a97e-f3266c5737cd	Breast	62	D6F5C34A-0F5C-4AED-977A-74A1E5D50915	7B0B60C7-5FA0-440E-937F-8D82119330D6	TCGA-AR-A2LK-01A-11D-A17W-09	GRCh37-lite	TCGA-AR-A2LK	TCGA-BRCA	NA	s6746	Washington University School of Medicine	Mayo	United States	NO	T3	N2	Infiltrating Lobular Carcinoma	Stage III	A17W-09	FALSE
13722.58cfa82de4b0c9d6adf6a45b	58cfa82de4b0c9d6adf6a45b	46558eada33c446ae8c1b02d32740dab.filtered.	WGS	46558eada33c446ae8c1b02d32740dab	46558eada33c446ae8c1b02d32740dab.bam	31.03	NA	0.08	58cfa82de4b0c9d6adf6a45b	46558eada33c446ae8c1b02d32740dab.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IS-A3KA-01A	257DC623-41E1-4FA3-859C-C787DB10BD60	Primary Tumor	Illumina HiSeq	5c922de0-6304-416e-a0aa-1a0cb42f0938	Mesenchymal	73	F8495459-CAF7-47CA-9B6A-7FE11FF1BA11	D8F0BECD-FDA8-41F4-A424-E082F9EAE22C	TCGA-IS-A3KA-01A-11D-A21Q-09	GRCh37-lite	TCGA-IS-A3KA	TCGA-SARC	413	s2485	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf730ac	58cfa83ce4b0c9d6adf730ac	ac2e74d430052ab39f0e2d8a23113736.filtered.	WGS	ac2e74d430052ab39f0e2d8a23113736	ac2e74d430052ab39f0e2d8a23113736.bam	33.01	NA	0.1	58cfa83ce4b0c9d6adf730ac	ac2e74d430052ab39f0e2d8a23113736.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GI-A2C9-01A	9F6BE944-83DE-42AB-8738-F0022F475E61	Primary Tumor	Illumina HiSeq	5f4a8fdf-00c0-4ab7-8323-d04f23a9e4a8	Breast	58	143FC27D-E119-48FF-A5EA-BD6AAFC0404E	5DBF3203-CE73-41E4-BF9A-32FC856F73F5	TCGA-GI-A2C9-01A-11D-A21Q-09	GRCh37-lite	TCGA-GI-A2C9	TCGA-BRCA	NA	s5943	Washington University School of Medicine	ABS - IUPUI	United States	NO	T3	N0	Infiltrating Ductal Carcinoma	Stage IIB	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf72fbd	58cfa83ce4b0c9d6adf72fbd	a765afe852088b93b14f4f8d87893494.filtered.	WGS	a765afe852088b93b14f4f8d87893494	a765afe852088b93b14f4f8d87893494.bam	49.61	2.14	0.08	58cfa83ce4b0c9d6adf72fbd	a765afe852088b93b14f4f8d87893494.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RE-01A	08DA7C4C-3067-4BCF-9D7A-78566DF72E69	Primary Tumor	Illumina HiSeq	6ed22fe1-529a-4ad1-8eb3-f50a383e4df4	Breast	61	270BE245-2239-4E96-A917-79CCA40868BA	1EB62ABC-7928-405B-84CC-F091CA5347B2	TCGA-B6-A0RE-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0RE	TCGA-BRCA	NA	s6250	Washington University School of Medicine	Duke	United States	NO	TX	N0 (i-)	Infiltrating Ductal Carcinoma	Stage X	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf730ed	58cfa83ce4b0c9d6adf730ed	b2e10818826b4072c8f92e5b678b4332.filtered.	WGS	b2e10818826b4072c8f92e5b678b4332	b2e10818826b4072c8f92e5b678b4332.bam	76.73	1.92	0.08	58cfa83ce4b0c9d6adf730ed	b2e10818826b4072c8f92e5b678b4332.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IQ-01A	01EEF340-598C-4205-A990-CEC190AC2CA5	Primary Tumor	Illumina HiSeq	7f45dc68-74e8-4953-8221-00c2ba51dee4	Breast	40	183A47B2-1B00-4A72-ADEB-F35B55692EE1	8956D73D-7E36-4129-8A3E-D4F3B43BAF0B	TCGA-B6-A0IQ-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0IQ	TCGA-BRCA	NA	s6102	Washington University School of Medicine	Duke	United States	NO	T3	N1b	Infiltrating Ductal Carcinoma	Stage IIIA	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf730e0	58cfa83ce4b0c9d6adf730e0	ee32938babfe9b6967e9a4c5f49435dd.filtered.	WGS	ee32938babfe9b6967e9a4c5f49435dd	ee32938babfe9b6967e9a4c5f49435dd.bam	84.77	1.86	0.08	58cfa83ce4b0c9d6adf730e0	ee32938babfe9b6967e9a4c5f49435dd.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LD-01A	1200C8B7-A058-4C01-BBE2-04EC09A65245	Primary Tumor	Illumina HiSeq	d3a5aa02-ef8e-4ad1-adca-1c4b867fe524	Uterus	63	649DADDA-5823-4B0D-B5A2-49F501ADC029	9D2671B9-BD30-4E3C-AA74-01E31DD2531E	TCGA-AP-A0LD-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0LD	TCGA-UCEC	NA	s5185	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf730fa	58cfa83ce4b0c9d6adf730fa	c03fa22a7c8629afd7ba660ae443cddc.filtered.	WGS	c03fa22a7c8629afd7ba660ae443cddc	c03fa22a7c8629afd7ba660ae443cddc.bam	74.86	1.88	0.08	58cfa83ce4b0c9d6adf730fa	c03fa22a7c8629afd7ba660ae443cddc.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04Q-01A	B5FBA77B-1F50-4E71-95B2-566AFBA4BDD7	Primary Tumor	Illumina HiSeq	77a8d1fa-9421-4333-b128-8a4b8fddfc6f	Breast	48	E17E273D-6F53-4419-9F0C-1E4E667C5257	03B8122D-02D9-4AD0-96ED-001C0D100DE0	TCGA-A2-A04Q-01A-21D-A128-09	GRCh37-lite	TCGA-A2-A04Q	TCGA-BRCA	NA	s6903	Washington University School of Medicine	Walter Reed	None	NO	T1	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf730c0	58cfa83ce4b0c9d6adf730c0	fd78ff5c667f21aef8657e218f7021a2.filtered.	WGS	fd78ff5c667f21aef8657e218f7021a2	fd78ff5c667f21aef8657e218f7021a2.bam	24.76	NA	0.08	58cfa83ce4b0c9d6adf730c0	fd78ff5c667f21aef8657e218f7021a2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-FX-A3NJ-01A	7BAB6742-4E3D-4FCF-9B90-D3E0218B4D79	Primary Tumor	Illumina HiSeq	4031a13e-df1e-4608-8d52-01b9b1c04b9d	Mesenchymal	54	29FDA349-D725-4F69-BB11-95D5454400F4	408ED640-75F6-4346-BDD0-3B93C51ADAE5	TCGA-FX-A3NJ-01A-11D-A21Q-09	GRCh37-lite	TCGA-FX-A3NJ	TCGA-SARC	NA	s2672	Washington University School of Medicine	International Genomics Consortium	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf7313a	58cfa83ce4b0c9d6adf7313a	ff180684131876b77d5fa19e93aaeb1e.filtered.	WGS	ff180684131876b77d5fa19e93aaeb1e	ff180684131876b77d5fa19e93aaeb1e.bam	52.23	NA	0.08	58cfa83ce4b0c9d6adf7313a	ff180684131876b77d5fa19e93aaeb1e.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IW-A3M4-01A	0DA5EE6C-D012-4A57-9992-9D74937AAA5F	Primary Tumor	Illumina HiSeq	62a7d6f2-3b71-4449-83fe-da6beea65873	Mesenchymal	48	F854DB6B-57CB-4DA7-9252-B2ADE22C2675	6AA00162-6294-4CE7-B6B7-0C3452E24CD6	TCGA-IW-A3M4-01A-11D-A21Q-09	GRCh37-lite	TCGA-IW-A3M4	TCGA-SARC	NA	s2673	Washington University School of Medicine	Cedars Sinai	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf73142	58cfa83ce4b0c9d6adf73142	e9efaac16efc09098f681fd6fdda9266.filtered.	WGS	e9efaac16efc09098f681fd6fdda9266	e9efaac16efc09098f681fd6fdda9266.bam	31.62	NA	0.08	58cfa83ce4b0c9d6adf73142	e9efaac16efc09098f681fd6fdda9266.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LS-01A	39F68467-3D37-4B19-AA43-ED7B120C619D	Primary Tumor	Illumina HiSeq	c94a5ebc-7224-41b0-96e9-6b057d782253	Mesenchymal	78	386455AA-441E-4BD2-A0A7-AD2ED278E5E6	075FC96D-6742-4EF3-9369-482592AD3A2F	TCGA-DX-A3LS-01A-11D-A21Q-09	GRCh37-lite	TCGA-DX-A3LS	TCGA-SARC	275	s2471	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf731d0	58cfa83ce4b0c9d6adf731d0	ff361cc3e22a9619323ddbddf3aac564.filtered.	WGS	ff361cc3e22a9619323ddbddf3aac564	ff361cc3e22a9619323ddbddf3aac564.bam	49.41	NA	0.07	58cfa83ce4b0c9d6adf731d0	ff361cc3e22a9619323ddbddf3aac564.bam	Dead	MALE	Not available	Not available	Sarcoma	Aligned reads	TCGA-DX-A3U8-01A	D40C99D0-79F6-499D-B7F1-5FC4237CFC57	Primary Tumor	Illumina HiSeq	d104749e-66ed-4722-98a5-5d59447e5779	Mesenchymal	43	D40B2922-FA6A-4AFA-BDBF-7B517384AF74	729229FE-92B9-439B-ACD2-B49159116A41	TCGA-DX-A3U8-01A-11D-A29N-09	GRCh37-lite	TCGA-DX-A3U8	TCGA-SARC	138	s2638	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A29N-09	FALSE
13722.58cfa83ce4b0c9d6adf731b8	58cfa83ce4b0c9d6adf731b8	b063d293e0df48fc160fc08c84c39531.filtered.	WGS	b063d293e0df48fc160fc08c84c39531	b063d293e0df48fc160fc08c84c39531.bam	9.71	NA	0.08	58cfa83ce4b0c9d6adf731b8	b063d293e0df48fc160fc08c84c39531.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LW-01A	2CACD9D0-8414-4F17-8259-C9D838597F39	Primary Tumor	Illumina HiSeq	0524db0d-7118-4575-ae31-3f7ebbf000c4	Mesenchymal	43	E25B5088-A3D4-4F3C-8335-308C571F6A30	9D691FA3-5C32-4B98-85C4-F6E0FD4C37E0	TCGA-DX-A3LW-01A-21D-A21Q-09	GRCh37-lite	TCGA-DX-A3LW	TCGA-SARC	NA	s2460	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf7308c	58cfa83ce4b0c9d6adf7308c	faba826f62de3e18afab489ceee4b813.filtered.	WGS	faba826f62de3e18afab489ceee4b813	faba826f62de3e18afab489ceee4b813.bam	6.41	NA	0.07	58cfa83ce4b0c9d6adf7308c	faba826f62de3e18afab489ceee4b813.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A1KW-01A	CD73A55F-03C1-4DA0-9FA7-1AE4A263664E	Primary Tumor	Illumina HiSeq	1ac5c6a6-b264-4f58-b9fb-983c540128a7	Mesenchymal	67	4C93C0A4-73C4-48EF-91E0-40B2143833BC	63DB50D6-5EF2-44D0-9906-26EAE74ECF44	TCGA-DX-A1KW-01A-22D-A24N-09	GRCh37-lite	TCGA-DX-A1KW	TCGA-SARC	NA	s2636	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf73082	58cfa83ce4b0c9d6adf73082	f56bc74c20a188c53b338d30ab71d4e2.filtered.	WGS	f56bc74c20a188c53b338d30ab71d4e2	f56bc74c20a188c53b338d30ab71d4e2.bam	89.42	1.98	0.08	58cfa83ce4b0c9d6adf73082	f56bc74c20a188c53b338d30ab71d4e2.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1BJ-01A	7941D1C7-5319-4E8D-A15F-60B61CB68A9B	Primary Tumor	Illumina HiSeq	0990b367-e2b6-4b2a-8ca1-dd9efab1866a	Cervix	34	C7B95D35-7FE9-4C25-94C6-AE6D7416A5C7	43BE43CB-A367-4A74-94E4-973ACAFCF576	TCGA-C5-A1BJ-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1BJ	TCGA-CESC	NA	s1344	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a464	58cfa82de4b0c9d6adf6a464	459f50a1a35d272785306ecb71cc5754.filtered.	WGS	459f50a1a35d272785306ecb71cc5754	459f50a1a35d272785306ecb71cc5754.bam	39.58	NA	0.08	58cfa82de4b0c9d6adf6a464	459f50a1a35d272785306ecb71cc5754.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-FX-A2QS-01A	2905CBD1-719B-46D9-B8AF-8FE4927BC473	Primary Tumor	Illumina HiSeq	8906cefc-240d-4590-8d00-1004fa85fd22	Mesenchymal	61	5402D273-3B02-4BF7-A0A4-625A59FED4CC	7D332CB1-BA25-47E4-8BF8-D25E14F40D59	TCGA-FX-A2QS-01A-11D-A21Q-09	GRCh37-lite	TCGA-FX-A2QS	TCGA-SARC	NA	s2486	Washington University School of Medicine	International Genomics Consortium	None	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a444	58cfa82de4b0c9d6adf6a444	05b05a3f284cf713011e4bd81b09ab5e.filtered.	WGS	05b05a3f284cf713011e4bd81b09ab5e	05b05a3f284cf713011e4bd81b09ab5e.bam	26.91	1.86	0.07	58cfa82de4b0c9d6adf6a444	05b05a3f284cf713011e4bd81b09ab5e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0AV-01A	790FF5DB-B7F3-4946-AAED-305F66B1DD6A	Primary Tumor	Illumina HiSeq	b2a1b1a3-a780-4be9-9a65-8937ba5df3b0	Breast	52	DCE6CAC3-6C76-4574-B7A8-C7083B12F22E	9032B7FE-E38A-4641-A45E-67041668ADC4	TCGA-BH-A0AV-01A-31D-A10Y-09	GRCh37-lite	TCGA-BH-A0AV	TCGA-BRCA	NA	s6450	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A10Y-09	FALSE
13722.58cfa82de4b0c9d6adf6a4a6	58cfa82de4b0c9d6adf6a4a6	3a96e8c557be05593e3dbb1fccbb73d1.filtered.	WGS	3a96e8c557be05593e3dbb1fccbb73d1	3a96e8c557be05593e3dbb1fccbb73d1.bam	74.02	2.18	0.09	58cfa82de4b0c9d6adf6a4a6	3a96e8c557be05593e3dbb1fccbb73d1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PB-01A	88DB1340-E4BF-451A-87C0-6E9168296F5E	Primary Tumor	Illumina HiSeq	2ba1984b-043e-4cc5-8bc4-10b6c2915f61	Breast	70	DA9DC40B-0350-4B8C-8A7A-15100D5AEB90	9DDF2119-A222-4FA5-A9F3-0BEC7EEEA36B	TCGA-EW-A1PB-01A-11D-A142-09	GRCh37-lite	TCGA-EW-A1PB	TCGA-BRCA	NA	s6454	Washington University School of Medicine	University of Miami	United States	NO	T3	N1a	Infiltrating Ductal Carcinoma	Stage IIIA	A142-09	FALSE
13722.58cfa82de4b0c9d6adf6a4a8	58cfa82de4b0c9d6adf6a4a8	1460837133c752e48d8ded9f16cc5949.filtered.	WGS	1460837133c752e48d8ded9f16cc5949	1460837133c752e48d8ded9f16cc5949.bam	43.68	1.56	0.08	58cfa82de4b0c9d6adf6a4a8	1460837133c752e48d8ded9f16cc5949.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LK-01A	1D27253F-B036-44E7-A04D-8DA5BBF57419	Primary Tumor	Illumina HiSeq	cdbdb1d9-4c6d-4a22-8867-42722b596ae9	Breast	84	CC937913-802F-48CD-A490-E6B90F007C5D	4E84EED6-82A8-4E91-B0FD-61EC6EF69CE9	TCGA-E2-A1LK-01A-21D-A14G-09	GRCh37-lite	TCGA-E2-A1LK	TCGA-BRCA	266	s6757	Washington University School of Medicine	Roswell Park	United States	NO	T4b	N3a	Infiltrating Ductal Carcinoma	Stage IIIC	A14G-09	FALSE
13722.58cfa82de4b0c9d6adf6a4b2	58cfa82de4b0c9d6adf6a4b2	1d839fbbdcb1971d9a0ef13b9f7a8b2e.filtered.	WGS	1d839fbbdcb1971d9a0ef13b9f7a8b2e	1d839fbbdcb1971d9a0ef13b9f7a8b2e.bam	69.79	1.98	0.08	58cfa82de4b0c9d6adf6a4b2	1d839fbbdcb1971d9a0ef13b9f7a8b2e.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A0AT-01A	05506F4C-E701-4A9D-AE06-97F066AADE43	Primary Tumor	Illumina HiSeq	5285cd99-09bc-48e5-abcb-11230d5f40f0	Breast	62	B2905A3F-810B-4E74-AF5C-42D513D91746	F848B66F-BD9E-4FBA-AFD4-EB58848D1EF4	TCGA-AN-A0AT-01A-11D-A045-09	GRCh37-lite	TCGA-AN-A0AT	TCGA-BRCA	NA	s6760	Washington University School of Medicine	Cureline	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A045-09	FALSE
13722.58cfa82de4b0c9d6adf6a50c	58cfa82de4b0c9d6adf6a50c	437fd4c58a0c6f406413c5f2b3073d0a.filtered.	WGS	437fd4c58a0c6f406413c5f2b3073d0a	437fd4c58a0c6f406413c5f2b3073d0a.bam	63.5	1.98	0.08	58cfa82de4b0c9d6adf6a50c	437fd4c58a0c6f406413c5f2b3073d0a.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A156-01A	F05D314C-5EC5-4E2A-B785-9A702716F111	Primary Tumor	Illumina HiSeq	3d9a2788-2bc3-4df9-bae7-fef37f6096b8	Breast	61	9D39F2CF-84B5-45BA-8C40-0A42D8F303B7	2DA2B745-068D-408C-9163-3B3A78D4AAED	TCGA-E2-A156-01A-11D-A314-09	GRCh37-lite	TCGA-E2-A156	TCGA-BRCA	NA	s6622	Washington University School of Medicine	Roswell Park	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a50e	58cfa82de4b0c9d6adf6a50e	29084d88d2f33ba899ea13cb6d938384.filtered.	WGS	29084d88d2f33ba899ea13cb6d938384	29084d88d2f33ba899ea13cb6d938384.bam	41.07	1.97	0.07	58cfa82de4b0c9d6adf6a50e	29084d88d2f33ba899ea13cb6d938384.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A0XR-01A	F51AF6DB-2655-47FB-9FFC-83A503A728EA	Primary Tumor	Illumina HiSeq	19e1e7d4-80dd-4107-98b2-6796fe22947f	Breast	55	6EDCDB8A-80E8-42A8-86FF-3950C1F3CB89	E7DC7492-3A84-49C7-8DEA-8F508B53DC40	TCGA-AN-A0XR-01A-11D-A10G-09	GRCh37-lite	TCGA-AN-A0XR	TCGA-BRCA	NA	s5477	Washington University School of Medicine	Cureline	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage IIIA	A10G-09	FALSE
13722.58cfa82de4b0c9d6adf6a52e	58cfa82de4b0c9d6adf6a52e	103f34ff20cea99f215bfb7393f043b8.filtered.	WGS	103f34ff20cea99f215bfb7393f043b8	103f34ff20cea99f215bfb7393f043b8.bam	45.75	2	0.09	58cfa82de4b0c9d6adf6a52e	103f34ff20cea99f215bfb7393f043b8.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A259-01A	3FC3755D-A3F8-4E2C-813F-FF124F2A75C1	Primary Tumor	Illumina HiSeq	767c5435-e3e1-4cdb-92e0-2b0961610118	Breast	70	EB2DE640-6C2A-4C8A-87C3-80F9FBDC3D9B	13D05F7A-E16A-40EF-9A15-21257DA2CF89	TCGA-A2-A259-01A-11D-A314-09	GRCh37-lite	TCGA-A2-A259	TCGA-BRCA	NA	s5785	Washington University School of Medicine	Walter Reed	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a526	58cfa82de4b0c9d6adf6a526	54edfd331e278de330c2f6fc9d8b6e06.filtered.	WGS	54edfd331e278de330c2f6fc9d8b6e06	54edfd331e278de330c2f6fc9d8b6e06.bam	45.22	2.08	0.08	58cfa82de4b0c9d6adf6a526	54edfd331e278de330c2f6fc9d8b6e06.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15H-01A	5580B21A-2CDB-4777-AD79-6E06654144F5	Primary Tumor	Illumina HiSeq	f359078d-7930-4e46-a5d4-3978f5434622	Breast	38	7CB99442-005B-4611-94F9-03AF195EC7E3	6D7F44DF-E9F0-4542-A6D8-D14EE7804002	TCGA-E2-A15H-01A-11D-A19H-09	GRCh37-lite	TCGA-E2-A15H	TCGA-BRCA	NA	s5479	Washington University School of Medicine	Roswell Park	None	NO	T1c	N1mi	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a53c	58cfa82de4b0c9d6adf6a53c	450a0ae734ab89c01b82ea2af8dacc92.filtered.	WGS	450a0ae734ab89c01b82ea2af8dacc92	450a0ae734ab89c01b82ea2af8dacc92.bam	75.68	1.83	0.09	58cfa82de4b0c9d6adf6a53c	450a0ae734ab89c01b82ea2af8dacc92.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A25B-01A	EADF8482-E60E-4307-ADB7-D5C3B9FA6CAE	Primary Tumor	Illumina HiSeq	372d2951-a381-41f0-88d7-72cc9da6b6db	Breast	39	2C619641-7849-4837-AB92-0DA80342B3E9	6E839EAF-1DBB-43F5-8846-C980E05540C7	TCGA-A2-A25B-01A-11D-A167-09	GRCh37-lite	TCGA-A2-A25B	TCGA-BRCA	NA	s6761	Washington University School of Medicine	Walter Reed	United States	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB	A167-09	FALSE
13722.58cfa82de4b0c9d6adf6a47e	58cfa82de4b0c9d6adf6a47e	2c5b37c2fff4a62ce10d93452de3771f.filtered.	WGS	2c5b37c2fff4a62ce10d93452de3771f	2c5b37c2fff4a62ce10d93452de3771f.bam	52.88	1.88	0.08	58cfa82de4b0c9d6adf6a47e	2c5b37c2fff4a62ce10d93452de3771f.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D1-01A	084C6AEC-94F7-4090-8F3F-59FA9E89721A	Primary Tumor	Illumina HiSeq	6d37aa75-54cd-423e-987a-342e9a2def7a	Breast	76	12ECE355-F1D0-446C-84E9-0AED3E6D29F8	E5593865-5F8E-4A4C-B36F-73FBE64D66DA	TCGA-A2-A0D1-01A-11D-A19H-09	GRCh37-lite	TCGA-A2-A0D1	TCGA-BRCA	NA	s5476	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a574	58cfa82de4b0c9d6adf6a574	2cf824ff67beaee254d0025b0c57ecfb.filtered.	WGS	2cf824ff67beaee254d0025b0c57ecfb	2cf824ff67beaee254d0025b0c57ecfb.bam	23.2	1.82	0.08	58cfa82de4b0c9d6adf6a574	2cf824ff67beaee254d0025b0c57ecfb.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A27H-01A	0DCA98B0-F43E-45B6-9A02-00092C78678C	Primary Tumor	Illumina HiSeq	bdde252c-e43c-448b-8e22-1ff90c7c957b	Breast	72	B7542984-1410-45E6-B936-8333FF902EB4	6764E0A2-7A78-45C1-9189-6001C6518CE4	TCGA-D8-A27H-01A-11D-A314-09	GRCh37-lite	TCGA-D8-A27H	TCGA-BRCA	NA	s5786	Washington University School of Medicine	Greater Poland Cancer Center	Poland	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a471	58cfa82de4b0c9d6adf6a471	1076369c844452a633e3edce84850064.filtered.	WGS	1076369c844452a633e3edce84850064	1076369c844452a633e3edce84850064.bam	59.16	1.89	0.09	58cfa82de4b0c9d6adf6a471	1076369c844452a633e3edce84850064.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A1C8-01A	BAD34C92-1E64-4187-A0B4-061105FD13BA	Primary Tumor	Illumina HiSeq	37d56097-9e5d-4008-bbc9-5bd69910436b	Uterus	77	83E4DFB0-F240-476B-BC25-F9F52C960AF5	00DB4DC2-3EC7-4FF9-9233-D69C8C8A607F	TCGA-AX-A1C8-01A-11D-A135-09	GRCh37-lite	TCGA-AX-A1C8	TCGA-UCEC	NA	s4403	Washington University School of Medicine	Gynecologic Oncology Group	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A135-09	FALSE
13722.58cfa82de4b0c9d6adf6a56a	58cfa82de4b0c9d6adf6a56a	2be207283820c51539ebdfde69ab84ca.filtered.	WGS	2be207283820c51539ebdfde69ab84ca	2be207283820c51539ebdfde69ab84ca.bam	58.3	1.95	0.08	58cfa82de4b0c9d6adf6a56a	2be207283820c51539ebdfde69ab84ca.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1P8-01A	359F12F9-5C41-48A4-85BC-FD7E307BF7D8	Primary Tumor	Illumina HiSeq	3a2f0cf6-0405-4ef6-be7e-75054acf1343	Breast	58	BF055644-7BCA-43B6-8F5A-E21C42F7CF88	E55F338F-97E2-4394-AE23-C92606069485	TCGA-EW-A1P8-01A-11D-A142-09	GRCh37-lite	TCGA-EW-A1P8	TCGA-BRCA	239	s5627	Washington University School of Medicine	University of Miami	United States	NO	T2	N3b	Infiltrating Ductal Carcinoma	Stage IIIC	A142-09	FALSE
13722.58cfa82de4b0c9d6adf6a58a	58cfa82de4b0c9d6adf6a58a	186d1b12be64c51f2303cdddde357025.filtered.	WGS	186d1b12be64c51f2303cdddde357025	186d1b12be64c51f2303cdddde357025.bam	89.92	1.91	0.08	58cfa82de4b0c9d6adf6a58a	186d1b12be64c51f2303cdddde357025.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1M9-01A	A3BE445A-A592-4073-815B-47AE41F9C4A0	Primary Tumor	Illumina HiSeq	e9ec290e-cad8-4af0-8b69-cf804598a951	Cervix	46	577057AF-7775-497B-BEE9-E04562648509	B9D1A64E-D445-4174-A5B4-76DD6EA69419	TCGA-C5-A1M9-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1M9	TCGA-CESC	1065	s1346	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T3b	N1	Endocervical Type of Adenocarcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a591	58cfa82de4b0c9d6adf6a591	682471ccf3c736af5187920ac83b2068.filtered.	WGS	682471ccf3c736af5187920ac83b2068	682471ccf3c736af5187920ac83b2068.bam	15.25	2.03	0.08	58cfa82de4b0c9d6adf6a591	682471ccf3c736af5187920ac83b2068.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0EA-01A	1F601832-EEE3-48FB-ACF5-80C4A454F26E	Primary Tumor	Illumina HiSeq	b1ff5cfd-0f6e-4211-a58a-81b120d0eb6d	Breast	72	7F791228-DD77-4AB0-8227-D784A4C7FEA1	EEF9DCE1-6BA6-432B-BBE2-53C7DBE64FE7	TCGA-BH-A0EA-01A-11D-A314-09	GRCh37-lite	TCGA-BH-A0EA	TCGA-BRCA	991	s5949	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a5b8	58cfa82de4b0c9d6adf6a5b8	61a02d82b4437f653c127eb3d3e0a78d.filtered.	WGS	61a02d82b4437f653c127eb3d3e0a78d	61a02d82b4437f653c127eb3d3e0a78d.bam	50.85	1.97	0.08	58cfa82de4b0c9d6adf6a5b8	61a02d82b4437f653c127eb3d3e0a78d.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A14X-01A	60DF7543-6DA5-4C75-943B-5800C1E08234	Primary Tumor	Illumina HiSeq	775348e1-91bf-4bf9-93e9-ff9f955b5a79	Breast	55	A7CC9298-D6F1-48EF-A93A-9C75FC0CB800	74039ACD-5ACA-4C65-818C-3B577D295BE0	TCGA-E2-A14X-01A-11D-A10Y-09	GRCh37-lite	TCGA-E2-A14X	TCGA-BRCA	NA	s6116	Washington University School of Medicine	Roswell Park	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage IIIA	A10Y-09	FALSE
13722.58cfa82de4b0c9d6adf6a596	58cfa82de4b0c9d6adf6a596	5f3d3040681cc587e66a46c6fe973f92.filtered.	WGS	5f3d3040681cc587e66a46c6fe973f92	5f3d3040681cc587e66a46c6fe973f92.bam	97.64	1.84	0.08	58cfa82de4b0c9d6adf6a596	5f3d3040681cc587e66a46c6fe973f92.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-DS-A0VL-01A	DFD30F94-19E3-4838-95DF-14A3763419AF	Primary Tumor	Illumina HiSeq	2c9bc14c-a6d3-4389-8360-024e9c04a5d4	Cervix	25	CDF4AB19-F243-4EFC-A5DC-8253CBE48845	E07991A4-0901-4ED1-8704-AA376565D862	TCGA-DS-A0VL-01A-21D-A200-09	GRCh37-lite	TCGA-DS-A0VL	TCGA-CESC	NA	s1350	Washington University School of Medicine	Cedars Sinai	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a5de	58cfa82de4b0c9d6adf6a5de	6541447d40abf6e8944eb0fde79c5bb3.filtered.	WGS	6541447d40abf6e8944eb0fde79c5bb3	6541447d40abf6e8944eb0fde79c5bb3.bam	42.49	NA	0.08	58cfa82de4b0c9d6adf6a5de	6541447d40abf6e8944eb0fde79c5bb3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LU-01A	E786DE34-4C21-460F-89AB-008DE4347049	Primary Tumor	Illumina HiSeq	5f6336e7-c966-4e89-81bd-15a9523a893c	Mesenchymal	60	39BBAA83-8143-4E62-836E-1584B41B073B	7D734D06-F2B1-4924-A201-620AC8084C49	TCGA-DX-A3LU-01A-11D-A21Q-09	GRCh37-lite	TCGA-DX-A3LU	TCGA-SARC	NA	s2489	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a5fc	58cfa82de4b0c9d6adf6a5fc	5e859f6467c712851a78fd973b655dc1.filtered.	WGS	5e859f6467c712851a78fd973b655dc1	5e859f6467c712851a78fd973b655dc1.bam	106.84	1.77	0.08	58cfa82de4b0c9d6adf6a5fc	5e859f6467c712851a78fd973b655dc1.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LL-01A	D17668C4-5D66-4E16-8B70-B54616581AAE	Primary Tumor	Illumina HiSeq	56b1f38e-7065-46ee-8f41-f17603791f9f	Uterus	56	488A7462-8348-422C-91D3-7D9F0C39D25E	0385961E-EA99-40B2-AD79-6872BC30D8A1	TCGA-AP-A0LL-01A-12D-A127-09	GRCh37-lite	TCGA-AP-A0LL	TCGA-UCEC	NA	s4412	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A127-09	FALSE
13722.58cfa82de4b0c9d6adf6a5c6	58cfa82de4b0c9d6adf6a5c6	7abe99091880688658f0fbf83d4b2209.filtered.	WGS	7abe99091880688658f0fbf83d4b2209	7abe99091880688658f0fbf83d4b2209.bam	100.8	1.86	0.09	58cfa82de4b0c9d6adf6a5c6	7abe99091880688658f0fbf83d4b2209.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1M8-01A	110CD100-5730-4873-9FAB-2AE6C8732062	Primary Tumor	Illumina HiSeq	bcb9d9ed-cd43-4eb0-a3e5-f667a80c20b7	Cervix	43	72FF7605-0905-4829-8B54-B76B45FBB0DF	07D20658-3DB4-47E7-877B-66536266EDFC	TCGA-C5-A1M8-01A-21D-A200-09	GRCh37-lite	TCGA-C5-A1M8	TCGA-CESC	NA	s1167	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b	N0	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a614	58cfa82de4b0c9d6adf6a614	511a3675203dfa8034f97dbe11cc6195.filtered.	WGS	511a3675203dfa8034f97dbe11cc6195	511a3675203dfa8034f97dbe11cc6195.bam	35.64	NA	0.08	58cfa82de4b0c9d6adf6a614	511a3675203dfa8034f97dbe11cc6195.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A2DF-01A	D6F7AFC0-1558-43AD-ACB1-2B5311ED2264	Primary Tumor	Illumina HiSeq	f577059e-baa8-4030-9baa-5857d30fbfec	Breast	53	66760E17-251D-4981-BB02-82C29B315080	7456ABD5-303E-4E6F-BF4E-47EFEFC7310F	TCGA-GM-A2DF-01A-11D-A17W-09	GRCh37-lite	TCGA-GM-A2DF	TCGA-BRCA	NA	s6763	Washington University School of Medicine	MD Anderson	United States	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A17W-09	FALSE
13722.58cfa82de4b0c9d6adf6a63e	58cfa82de4b0c9d6adf6a63e	4904c28d460c5452fabb15e54e66ee71.filtered.	WGS	4904c28d460c5452fabb15e54e66ee71	4904c28d460c5452fabb15e54e66ee71.bam	73.92	NA	0.09	58cfa82de4b0c9d6adf6a63e	4904c28d460c5452fabb15e54e66ee71.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PC-01B	F45210D3-9E66-4F5E-BEF1-5EE5547CC893	Primary Tumor	Illumina HiSeq	4ded0771-e685-45fb-99f1-4dc1212cc9fc	Breast	66	FB635F1D-5EE1-4E58-86EA-B1AADA2DE4BA	1C0E384F-7254-4AFE-93C0-B3FC6C6A7894	TCGA-EW-A1PC-01B-11D-A21Q-09	GRCh37-lite	TCGA-EW-A1PC	TCGA-BRCA	NA	s5789	Washington University School of Medicine	University of Miami	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a65c	58cfa82de4b0c9d6adf6a65c	4fa7ea559428c6a86aecf3aa8cb8acc0.filtered.	WGS	4fa7ea559428c6a86aecf3aa8cb8acc0	4fa7ea559428c6a86aecf3aa8cb8acc0.bam	44.55	NA	0.08	58cfa82de4b0c9d6adf6a65c	4fa7ea559428c6a86aecf3aa8cb8acc0.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A2IZ-01A	6B189EFF-B919-49D6-8775-DBF32C9CCBBA	Primary Tumor	Illumina HiSeq	a3746833-4b30-4c7f-b95c-b534566de66c	Mesenchymal	60	B68F7194-1F05-4009-8ED2-58C5EBBCABA8	67BB70B2-B6F8-4AA9-80CE-48829F9FEC56	TCGA-DX-A2IZ-01A-11D-A21Q-09	GRCh37-lite	TCGA-DX-A2IZ	TCGA-SARC	NA	s2488	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a668	58cfa82de4b0c9d6adf6a668	7bb361e97c34cfa7d98b7297a5f65604.filtered.	WGS	7bb361e97c34cfa7d98b7297a5f65604	7bb361e97c34cfa7d98b7297a5f65604.bam	92.8	2.11	0.08	58cfa82de4b0c9d6adf6a668	7bb361e97c34cfa7d98b7297a5f65604.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GJ-01A	94817E78-78F5-4556-9394-610DF65605E2	Primary Tumor	Illumina HiSeq	b55c1811-4356-4978-a0f1-59bda1ab8a8c	Uterus	44	48FA5B7D-E488-4743-A7CE-ACEB9945F00B	B38D0777-4901-48B8-9CDC-33B7F13A424F	TCGA-A5-A0GJ-01A-11D-A325-09	GRCh37-lite	TCGA-A5-A0GJ	TCGA-UCEC	NA	s4240	Washington University School of Medicine	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A325-09	TRUE
13722.58cfa82de4b0c9d6adf6a678	58cfa82de4b0c9d6adf6a678	5ccefc1bca215bf54bcca30953e25fc3.filtered.	WGS	5ccefc1bca215bf54bcca30953e25fc3	5ccefc1bca215bf54bcca30953e25fc3.bam	87.84	2.05	0.09	58cfa82de4b0c9d6adf6a678	5ccefc1bca215bf54bcca30953e25fc3.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AJ-A23M-01A	D39DF936-4BC6-404D-9E1D-F6416CC5A34C	Primary Tumor	Illumina HiSeq	c45046fe-9086-4f96-bc47-68de65413b58	Uterus	61	ACBBC556-4E4E-4EBC-B408-55D69720A87D	96F337D2-CEC4-4484-87CD-AB2109D2BF50	TCGA-AJ-A23M-01A-11D-A34H-09	GRCh37-lite	TCGA-AJ-A23M	TCGA-UCEC	NA	s4238	Washington University School of Medicine	International Genomics Conosrtium	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A34H-09	TRUE
13722.58cfa82de4b0c9d6adf6a69f	58cfa82de4b0c9d6adf6a69f	824558b943d0281e9fdc0f4e97a69b78.filtered.	WGS	824558b943d0281e9fdc0f4e97a69b78	824558b943d0281e9fdc0f4e97a69b78.bam	71.16	2.03	0.08	58cfa82de4b0c9d6adf6a69f	824558b943d0281e9fdc0f4e97a69b78.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H6-01A	AEB6A3A6-B57A-4C53-90E6-E833777DD2A1	Primary Tumor	Illumina HiSeq	8df89d9c-2eb9-459a-adf7-48c9867c9462	Breast	82	B2921C9D-C655-46F3-86E5-2FC2BED1ED33	AA58C09A-7799-4675-8310-D270224B163E	TCGA-BH-A0H6-01A-21D-A314-09	GRCh37-lite	TCGA-BH-A0H6	TCGA-BRCA	NA	s5792	Washington University School of Medicine	University of Pittsburgh	None	NO	T1b	NX	Infiltrating Ductal Carcinoma	Stage I	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a642	58cfa82de4b0c9d6adf6a642	56c4e1fd143ea68f16ed05f49f2cd315.filtered.	WGS	56c4e1fd143ea68f16ed05f49f2cd315	56c4e1fd143ea68f16ed05f49f2cd315.bam	29.64	1.95	0.07	58cfa82de4b0c9d6adf6a642	56c4e1fd143ea68f16ed05f49f2cd315.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A14P-01A	E4FC0909-F284-4471-866D-D8967B6ADCBC	Primary Tumor	Illumina HiSeq	6291117d-64a7-4c35-94bb-8e06275c498e	Breast	79	58BFE278-A80F-4722-B286-4D966214D244	74B57D2C-A83F-4798-B86B-A533975E4CC0	TCGA-E2-A14P-01A-31D-A19H-09	GRCh37-lite	TCGA-E2-A14P	TCGA-BRCA	NA	s5629	Washington University School of Medicine	Roswell Park	None	NO	T2	N3	Infiltrating Ductal Carcinoma	Stage IIIC	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a69e	58cfa82de4b0c9d6adf6a69e	898a39476e967ce15adbf5f7f4230feb.filtered.	WGS	898a39476e967ce15adbf5f7f4230feb	898a39476e967ce15adbf5f7f4230feb.bam	60.86	NA	0.09	58cfa82de4b0c9d6adf6a69e	898a39476e967ce15adbf5f7f4230feb.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2LT-01A	FB66B7F5-22CA-4D4D-97C2-30E6EDFFF781	Primary Tumor	Illumina HiSeq	f6c6e1bd-966a-4f96-b8ab-e8219607f960	Cervix	38	EEDE6958-96A5-433D-8823-503B58559ED4	0F6B355E-3898-4BE6-BE97-DA0C3840A4ED	TCGA-C5-A2LT-01A-11D-A18J-09	GRCh37-lite	TCGA-C5-A2LT	TCGA-CESC	NA	s1512	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b	N0	Cervical Squamous Cell Carcinoma	Not available	A18J-09	TRUE
13722.58cfa82de4b0c9d6adf6a658	58cfa82de4b0c9d6adf6a658	56ee38b83bbac3302bd71fef66bd52a5.filtered.	WGS	56ee38b83bbac3302bd71fef66bd52a5	56ee38b83bbac3302bd71fef66bd52a5.bam	73.22	2.09	0.07	58cfa82de4b0c9d6adf6a658	56ee38b83bbac3302bd71fef66bd52a5.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0JN-01A	B60F22AC-A659-4F33-B01D-820E86A9A5C9	Primary Tumor	Illumina HiSeq	4a8180de-0459-43a0-9e22-6a115e56912c	Uterus	84	684C6894-FD49-4934-8962-9628ECE734FB	8DD14F0E-8601-4AA1-864C-3C49E768CDD1	TCGA-B5-A0JN-01A-11D-A10B-09	GRCh37-lite	TCGA-B5-A0JN	TCGA-UCEC	NA	s4410	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A10B-09	TRUE
13722.58cfa82de4b0c9d6adf6a6c4	58cfa82de4b0c9d6adf6a6c4	890d7ec2b62541e2e80696ea62529008.filtered.	WGS	890d7ec2b62541e2e80696ea62529008	890d7ec2b62541e2e80696ea62529008.bam	63.32	NA	0.07	58cfa82de4b0c9d6adf6a6c4	890d7ec2b62541e2e80696ea62529008.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RM-01A	C13215D9-26A8-4C8B-B4FE-5DA6AA3222AF	Primary Tumor	Illumina HiSeq	4bb49662-4b46-4288-a828-c518e6d697b2	Cervix	40	F0CA60FB-BD45-4F15-A791-0C5B1218D8EF	801E67C8-C506-410A-BDF0-856A66E974F4	TCGA-EK-A2RM-01A-21D-A18J-09	GRCh37-lite	TCGA-EK-A2RM	TCGA-CESC	NA	s1168	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A18J-09	TRUE
13722.58cfa82de4b0c9d6adf6a6bc	58cfa82de4b0c9d6adf6a6bc	96931b4ebc549e6fc4857a1d420bb860.filtered.	WGS	96931b4ebc549e6fc4857a1d420bb860	96931b4ebc549e6fc4857a1d420bb860.bam	63.14	2.06	0.07	58cfa82de4b0c9d6adf6a6bc	96931b4ebc549e6fc4857a1d420bb860.bam	Dead	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A08L-01A	8BD68696-5EEB-46D7-9DC6-C39C849029A4	Primary Tumor	Illumina HiSeq	941e2188-e858-40d6-9f12-5faa6425a67f	Breast	89	C385C7FC-0E3E-4FC8-87C1-6DB442E5606F	FE04D042-A4CC-4A14-8197-415EA40951AA	TCGA-A8-A08L-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A08L	TCGA-BRCA	304	s5634	Washington University School of Medicine	Indivumed	Germany	NO	T3	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a6cf	58cfa82de4b0c9d6adf6a6cf	943f4d785b943d37fff5ff0c234c4566.filtered.	WGS	943f4d785b943d37fff5ff0c234c4566	943f4d785b943d37fff5ff0c234c4566.bam	87.75	1.92	0.08	58cfa82de4b0c9d6adf6a6cf	943f4d785b943d37fff5ff0c234c4566.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16G-01A	16E69011-C295-479F-B521-86E66FBA498D	Primary Tumor	Illumina HiSeq	e4699f4c-2332-49b2-83cb-aff2eeb83c5b	Uterus	74	4C34ECB0-9351-4A55-9FF5-2062B7CB391A	65F9A820-F026-4A10-8BB7-1FBC3B38321E	TCGA-D1-A16G-01A-31D-A12J-09	GRCh37-lite	TCGA-D1-A16G	TCGA-UCEC	834	s4770	Washington University School of Medicine	Mayo Clinic	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A12J-09	FALSE
13722.58cfa82de4b0c9d6adf6a530	58cfa82de4b0c9d6adf6a530	11e9896c1184c4a8c38f78209b067bcf.filtered.	WGS	11e9896c1184c4a8c38f78209b067bcf	11e9896c1184c4a8c38f78209b067bcf.bam	31.82	1.93	0.08	58cfa82de4b0c9d6adf6a530	11e9896c1184c4a8c38f78209b067bcf.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TG-01A	13F31BCB-BEFD-4ED2-ADC0-DC9E9CE52B75	Primary Tumor	Illumina HiSeq	8a9ac951-0c3a-4112-8159-d585756fae14	Uterus	60	36E44603-A1EE-4A5B-9506-49A9358BF8D0	19DEF402-FB8D-4B27-90DD-CE9135A3C0A2	TCGA-BS-A0TG-01A-32D-A10B-09	GRCh37-lite	TCGA-BS-A0TG	TCGA-UCEC	NA	s4233	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10B-09	TRUE
13722.58cfa82de4b0c9d6adf6a708	58cfa82de4b0c9d6adf6a708	9e0aa323dd137c62bd3ba6626357862a.filtered.	WGS	9e0aa323dd137c62bd3ba6626357862a	9e0aa323dd137c62bd3ba6626357862a.bam	47.34	2	0.09	58cfa82de4b0c9d6adf6a708	9e0aa323dd137c62bd3ba6626357862a.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-E6-A1LZ-01A	9205C164-7975-421A-90C3-EDFE8DEF595C	Primary Tumor	Illumina HiSeq	d8f785e3-7de9-4e09-b830-5033e5eaa2f4	Uterus	76	62BFF77E-4FE6-4A9F-A867-345584608E7D	F7DCC2E4-1FC4-4B39-BC6A-720E66116D68	TCGA-E6-A1LZ-01A-11D-A142-09	GRCh37-lite	TCGA-E6-A1LZ	TCGA-UCEC	NA	s5193	Washington University School of Medicine	Roswell Park	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A142-09	FALSE
13722.58cfa82de4b0c9d6adf6a484	58cfa82de4b0c9d6adf6a484	2d65798c16f002af919022459ec3009d.filtered.	WGS	2d65798c16f002af919022459ec3009d	2d65798c16f002af919022459ec3009d.bam	20	NA	0.09	58cfa82de4b0c9d6adf6a484	2d65798c16f002af919022459ec3009d.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A1KU-01A	EA0E5AE7-1F15-4504-AEA3-EFD1F6733304	Primary Tumor	Illumina HiSeq	f73eec26-a9f4-4fb0-bbaa-ca6aa00f1a51	Mesenchymal	82	B09E1197-D6CD-4A76-8E2F-3B8AF97D2390	C556F81B-8A6C-4BBB-876F-2E2CE570C185	TCGA-DX-A1KU-01A-32D-A24N-09	GRCh37-lite	TCGA-DX-A1KU	TCGA-SARC	427	s2481	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72e9c	58cfa83ce4b0c9d6adf72e9c	c7d4da3dbfd3dbc673a6cbab28c5999b.filtered.	WGS	c7d4da3dbfd3dbc673a6cbab28c5999b	c7d4da3dbfd3dbc673a6cbab28c5999b.bam	83.75	1.81	0.08	58cfa83ce4b0c9d6adf72e9c	c7d4da3dbfd3dbc673a6cbab28c5999b.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A11I-01A	F6D136C7-C250-4361-9FED-50F513959A40	Primary Tumor	Illumina HiSeq	290cd155-e6e8-450c-89ce-7688b88465e9	Uterus	65	56652DDE-33DA-451E-A1C2-6E9884F9915A	31BC44B9-35FF-43FD-8A01-A834F3B1CE46	TCGA-B5-A11I-01A-11D-A10M-09	GRCh37-lite	TCGA-B5-A11I	TCGA-UCEC	NA	s4972	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10M-09	FALSE
13722.58cfa83ce4b0c9d6adf72ea2	58cfa83ce4b0c9d6adf72ea2	c365daeccf937ff8ec5b164169f4beb6.filtered.	WGS	c365daeccf937ff8ec5b164169f4beb6	c365daeccf937ff8ec5b164169f4beb6.bam	32.61	NA	0.08	58cfa83ce4b0c9d6adf72ea2	c365daeccf937ff8ec5b164169f4beb6.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3XX-01A	53886143-C1C6-40E9-88E6-E4E5E0271FC8	Primary Tumor	Illumina HiSeq	c11a6c92-3f76-42d3-aa9d-e1e4c34f7cf5	Breast	49	0A1F4A81-38C6-407A-A33B-716A0F9A6B4D	C67409B2-AC25-42A0-8543-4636EF132FE4	TCGA-A2-A3XX-01A-21D-A23C-09	GRCh37-lite	TCGA-A2-A3XX	TCGA-BRCA	NA	s5622	Washington University School of Medicine	Walter Reed	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A23C-09	FALSE
13722.58cfa83ce4b0c9d6adf72edf	58cfa83ce4b0c9d6adf72edf	e4a6e1d5b4230f26d94ced982fad1af3.filtered.	WGS	e4a6e1d5b4230f26d94ced982fad1af3	e4a6e1d5b4230f26d94ced982fad1af3.bam	94.6	1.95	0.08	58cfa83ce4b0c9d6adf72edf	e4a6e1d5b4230f26d94ced982fad1af3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A109-01A	F0787165-6F58-4D67-B510-928EEA2C4882	Primary Tumor	Illumina HiSeq	33884ffd-f43a-4cb9-beb0-9c0a7d6f3f31	Breast	64	710EAE35-A21D-4939-8414-D2AF4EA02FDD	3585E133-B3C1-4D90-B5F2-2B867E0AE0EC	TCGA-E2-A109-01A-11D-A10M-09	GRCh37-lite	TCGA-E2-A109	TCGA-BRCA	NA	s5623	Washington University School of Medicine	Roswell Park	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A10M-09	FALSE
13722.58cfa83ce4b0c9d6adf72eac	58cfa83ce4b0c9d6adf72eac	cfb494ec82ff531a0bc7eacc26f33717.filtered.	WGS	cfb494ec82ff531a0bc7eacc26f33717	cfb494ec82ff531a0bc7eacc26f33717.bam	83.96	1.98	0.08	58cfa83ce4b0c9d6adf72eac	cfb494ec82ff531a0bc7eacc26f33717.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GA-01A	71FED998-8FAC-4E6B-B38A-22C83E05E958	Primary Tumor	Illumina HiSeq	b68fc7e3-5a98-423d-8f72-b4b5f50435a5	Uterus	67	5A40330F-9307-4584-9557-5D19F2357FCC	577D5C9E-FBDA-41D5-B0B3-CDB733453EA5	TCGA-A5-A0GA-01A-11D-A066-09	GRCh37-lite	TCGA-A5-A0GA	TCGA-UCEC	543	s4763	Washington University School of Medicine	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf72f03	58cfa83ce4b0c9d6adf72f03	b66e82ee0591fe581241dcc082de2e52.filtered.	WGS	b66e82ee0591fe581241dcc082de2e52	b66e82ee0591fe581241dcc082de2e52.bam	56.36	1.95	0.07	58cfa83ce4b0c9d6adf72f03	b66e82ee0591fe581241dcc082de2e52.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17K-01A	5C22C8D6-5805-455C-8E1C-E6B8006738E4	Primary Tumor	Illumina HiSeq	03c25260-4914-4b4e-817e-05d0ba7e3ded	Uterus	74	CA213835-EFC5-4216-A762-A6B320B516BF	105A51C4-CC7E-4D0F-9CF8-E4D64A31D14D	TCGA-D1-A17K-01A-11D-A325-09	GRCh37-lite	TCGA-D1-A17K	TCGA-UCEC	NA	s5370	Washington University School of Medicine	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A325-09	TRUE
13722.58cfa83ce4b0c9d6adf72ef8	58cfa83ce4b0c9d6adf72ef8	d9a4fed4943a3f61117cf771e1db8985.filtered.	WGS	d9a4fed4943a3f61117cf771e1db8985	d9a4fed4943a3f61117cf771e1db8985.bam	57.99	NA	0.08	58cfa83ce4b0c9d6adf72ef8	d9a4fed4943a3f61117cf771e1db8985.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A2BK-01A	6FA2A667-9C36-4526-8A58-1975E863A806	Primary Tumor	Illumina HiSeq	53c5c882-8386-48e7-b7dd-8815bcf6b316	Breast	78	B85BE663-EDBA-4E1E-A10C-D0297744A0E9	8E03E773-5557-4E78-889B-4710C515378F	TCGA-AC-A2BK-01A-11D-A314-09	GRCh37-lite	TCGA-AC-A2BK	TCGA-BRCA	NA	s6750	Washington University School of Medicine	International Genomics Consortium	United States	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A314-09	TRUE
13722.58cfa83ce4b0c9d6adf72f7d	58cfa83ce4b0c9d6adf72f7d	e82f5efc1a18908b7a00b45b9bfd5e18.filtered.	WGS	e82f5efc1a18908b7a00b45b9bfd5e18	e82f5efc1a18908b7a00b45b9bfd5e18.bam	48.87	1.91	0.08	58cfa83ce4b0c9d6adf72f7d	e82f5efc1a18908b7a00b45b9bfd5e18.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A1AY-01A	5FD9552A-C742-4388-940D-295D1107AE00	Primary Tumor	Illumina HiSeq	45a65b22-252b-4f92-bd7b-16a76d26c165	Breast	65	81FC993E-8F5A-4B3B-BEA3-4C4C2F5E4EF2	15F90EF0-831B-40A3-98BD-EC226A9E8B26	TCGA-AR-A1AY-01A-21D-A12Q-09	GRCh37-lite	TCGA-AR-A1AY	TCGA-BRCA	NA	s6905	Washington University School of Medicine	Mayo	None	NO	T1	N0	Infiltrating Ductal Carcinoma	Stage I	A12Q-09	FALSE
13722.58cfa83ce4b0c9d6adf72f43	58cfa83ce4b0c9d6adf72f43	cee8053647191b1b4b10e3f58a90b606.filtered.	WGS	cee8053647191b1b4b10e3f58a90b606	cee8053647191b1b4b10e3f58a90b606.bam	83.38	1.91	0.08	58cfa83ce4b0c9d6adf72f43	cee8053647191b1b4b10e3f58a90b606.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LG-01A	EF4CBD38-BC79-4D60-A715-647EDD2EBE9E	Primary Tumor	Illumina HiSeq	c24e6791-401c-4b37-bfe6-669f050ea42e	Breast	50	B462982A-4DD0-425E-BCE3-0EB8F5527264	7CDBE0E8-F614-4F54-B864-FD6B39E8EF1C	TCGA-E2-A1LG-01A-21D-A14K-09	GRCh37-lite	TCGA-E2-A1LG	TCGA-BRCA	NA	s5781	Washington University School of Medicine	Roswell Park	United States	NO	T2	N0	Infiltrating Lobular Carcinoma	Stage IIA	A14K-09	FALSE
13722.58cfa83ce4b0c9d6adf72f19	58cfa83ce4b0c9d6adf72f19	ccd535b1664251ecbc0fb70ec7dee554.filtered.	WGS	ccd535b1664251ecbc0fb70ec7dee554	ccd535b1664251ecbc0fb70ec7dee554.bam	17.51	1.95	0.07	58cfa83ce4b0c9d6adf72f19	ccd535b1664251ecbc0fb70ec7dee554.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A03N-01B	9435447E-D65F-408B-863B-6576B1D652DD	Primary Tumor	Illumina HiSeq	a198d001-d09b-4a43-9704-060db667151f	Breast	59	06B3E3CA-24B9-4E19-9E59-B51CC6D6735B	F8F749B7-547D-49FA-9DA2-44EED962B6FD	TCGA-AO-A03N-01B-11D-A19H-09	GRCh37-lite	TCGA-AO-A03N	TCGA-BRCA	NA	s6749	Washington University School of Medicine	MSKCC	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf72fae	58cfa83ce4b0c9d6adf72fae	a67ab1214f8c6bab30f876560e45768a.filtered.	WGS	a67ab1214f8c6bab30f876560e45768a	a67ab1214f8c6bab30f876560e45768a.bam	61.5	NA	0.08	58cfa83ce4b0c9d6adf72fae	a67ab1214f8c6bab30f876560e45768a.bam	Alive	FEMALE	WHITE	Not available	Sarcoma	Aligned reads	TCGA-IS-A3K7-01A	5A64F7E9-3833-4A3C-962B-13EB3E305C69	Primary Tumor	Illumina HiSeq	244fb4fa-4623-4468-acf2-601bb7f70990	Mesenchymal	63	7254C2AC-D8AC-4D6E-B444-4CB5F8A6EB36	AFEE5B10-3DFF-4E50-9575-BC9FE20C5DEA	TCGA-IS-A3K7-01A-11D-A21Q-09	GRCh37-lite	TCGA-IS-A3K7	TCGA-SARC	NA	s2458	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf72fc8	58cfa83ce4b0c9d6adf72fc8	b939c2720803667f3b27acd9d4596892.filtered.	WGS	b939c2720803667f3b27acd9d4596892	b939c2720803667f3b27acd9d4596892.bam	36.4	NA	0.07	58cfa83ce4b0c9d6adf72fc8	b939c2720803667f3b27acd9d4596892.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-FX-A48G-01A	12BFD446-2EE5-4664-A492-C023D134F60F	Primary Tumor	Illumina HiSeq	1e67ee27-4af7-4e44-81ba-76ff196f16fb	Mesenchymal	56	CEEBA881-5A1D-4FDC-8C9D-D60B3FACECF2	CB5E1546-CDA6-4991-911C-F3DD9F1A475A	TCGA-FX-A48G-01A-11D-A24N-09	GRCh37-lite	TCGA-FX-A48G	TCGA-SARC	NA	s2464	Washington University School of Medicine	International Genomics Consortium	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72fec	58cfa83ce4b0c9d6adf72fec	f45b766a6494688451a4e74a68b954b5.filtered.	WGS	f45b766a6494688451a4e74a68b954b5	f45b766a6494688451a4e74a68b954b5.bam	31.78	NA	0.08	58cfa83ce4b0c9d6adf72fec	f45b766a6494688451a4e74a68b954b5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-HB-A43Z-01A	9C9B53E5-CDBE-4510-A839-4A3B5039681B	Primary Tumor	Illumina HiSeq	209a73b4-3820-4d16-9437-d67356ab9735	Mesenchymal	58	A6BBEE06-44BF-446A-8D21-550AA6E71960	16D33E09-2E21-4DA2-8E57-E78CE28C4408	TCGA-HB-A43Z-01A-11D-A24N-09	GRCh37-lite	TCGA-HB-A43Z	TCGA-SARC	NA	s2637	Washington University School of Medicine	University of North Carolina	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72f9e	58cfa83ce4b0c9d6adf72f9e	a10df74fe68e2f8902de76b1691f26cd.filtered.	WGS	a10df74fe68e2f8902de76b1691f26cd	a10df74fe68e2f8902de76b1691f26cd.bam	69.7	2	0.07	58cfa83ce4b0c9d6adf72f9e	a10df74fe68e2f8902de76b1691f26cd.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BK-A0CC-01A	2B865F8C-539F-4CB2-8F08-41709E9511E5	Primary Tumor	Illumina HiSeq	83ddf098-024c-49f8-80ef-b79b0b8182d5	Uterus	69	ED22CB10-EBDE-4019-9B6D-E19AB573CA94	E7D74D34-3255-4C20-90FD-B105E6E229C8	TCGA-BK-A0CC-01A-21D-A013-09	GRCh37-lite	TCGA-BK-A0CC	TCGA-UCEC	NA	s5180	Washington University School of Medicine	Christiana Healthcare	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa83ce4b0c9d6adf72f72	58cfa83ce4b0c9d6adf72f72	ea57989a2a3017624491e77218b0f326.filtered.	WGS	ea57989a2a3017624491e77218b0f326	ea57989a2a3017624491e77218b0f326.bam	44.27	1.98	0.08	58cfa83ce4b0c9d6adf72f72	ea57989a2a3017624491e77218b0f326.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15E-01A	0A2A3529-F645-4967-9A58-89EE20B8BB62	Primary Tumor	Illumina HiSeq	3b80e735-e034-4867-be5e-52500f523ab5	Breast	40	9992EEB9-901B-4A32-BADC-E9BE7C9BA4BA	92B515EB-4036-4DAD-9CCA-DFB59C2EF26E	TCGA-E2-A15E-01A-11D-A19H-09	GRCh37-lite	TCGA-E2-A15E	TCGA-BRCA	NA	s6753	Washington University School of Medicine	Roswell Park	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf7307f	58cfa83ce4b0c9d6adf7307f	b58386e952752d807a06a013a922b7ae.filtered.	WGS	b58386e952752d807a06a013a922b7ae	b58386e952752d807a06a013a922b7ae.bam	17.96	1.86	0.07	58cfa83ce4b0c9d6adf7307f	b58386e952752d807a06a013a922b7ae.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A13D-01A	8785012F-F73E-4D68-87CF-1D804AF32782	Primary Tumor	Illumina HiSeq	3c8a206a-59d4-412a-97c1-9dd31cb9b7c0	Breast	46	79FC9ED3-4E96-4C0E-869E-1756CBDABB39	418E916B-7A4E-4FAB-8616-15DCEC4D79F8	TCGA-A7-A13D-01A-13D-A12Q-09	GRCh37-lite	TCGA-A7-A13D	TCGA-BRCA	NA	s6443	Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A12Q-09	FALSE
13722.58cfa83ce4b0c9d6adf730ca	58cfa83ce4b0c9d6adf730ca	fe1ba68c47fad6337f26bbdac35cbb2b.filtered.	WGS	fe1ba68c47fad6337f26bbdac35cbb2b	fe1ba68c47fad6337f26bbdac35cbb2b.bam	43.03	NA	0.08	58cfa83ce4b0c9d6adf730ca	fe1ba68c47fad6337f26bbdac35cbb2b.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RL-01A	61EB08D0-EA01-45E7-884B-AC3D6070172A	Primary Tumor	Illumina HiSeq	5848efed-18c8-413b-8a2c-9a63deec56ee	Cervix	32	DD3E80D9-0321-40AD-B963-25E2C94C6092	842DF341-D34F-4ED6-928C-EAF15BF7F667	TCGA-EK-A2RL-01A-11D-A34H-09	GRCh37-lite	TCGA-EK-A2RL	TCGA-CESC	NA	s1507	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	T1b1	N1	Endocervical Type of Adenocarcinoma	Not available	A34H-09	TRUE
13722.58cfa83ce4b0c9d6adf730cb	58cfa83ce4b0c9d6adf730cb	fa894126e254827396a4f68e2b369bc2.filtered.	WGS	fa894126e254827396a4f68e2b369bc2	fa894126e254827396a4f68e2b369bc2.bam	34.01	1.86	0.08	58cfa83ce4b0c9d6adf730cb	fa894126e254827396a4f68e2b369bc2.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DG-01A	0BC5744C-5FA3-45BB-87D0-70A02068B392	Primary Tumor	Illumina HiSeq	d1c980ac-6070-4a3b-8ff8-208b0f7897cf	Breast	30	3F104CF7-8DE8-4E77-8BAA-BAD1BBB493AC	EC4D4CBC-D5D1-418D-A292-CAD9576624FD	TCGA-BH-A0DG-01A-21D-A12Q-09	GRCh37-lite	TCGA-BH-A0DG	TCGA-BRCA	NA	s6908	Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A12Q-09	FALSE
13722.58cfa83ce4b0c9d6adf7309a	58cfa83ce4b0c9d6adf7309a	be7bcf9d37d9e65a46acadb6e8e3450e.filtered.	WGS	be7bcf9d37d9e65a46acadb6e8e3450e	be7bcf9d37d9e65a46acadb6e8e3450e.bam	58.65	1.91	0.08	58cfa83ce4b0c9d6adf7309a	be7bcf9d37d9e65a46acadb6e8e3450e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BW-01A	5D1D00C6-FCAE-479E-AE1E-DE76EFD41D98	Primary Tumor	Illumina HiSeq	d87bcaa2-19f0-4c3b-8f85-8f47ed056ffc	Breast	71	DBEEDDC1-D149-46F7-91FF-D057F8C6BFFB	07B5141F-AC79-439B-883B-B0183BBE7FF5	TCGA-BH-A0BW-01A-11D-A10Y-09	GRCh37-lite	TCGA-BH-A0BW	TCGA-BRCA	NA	s6253	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A10Y-09	FALSE
13722.58cfa83ce4b0c9d6adf73128	58cfa83ce4b0c9d6adf73128	c71bbdff2d8e43b1dd7f270bf112e2c4.filtered.	WGS	c71bbdff2d8e43b1dd7f270bf112e2c4	c71bbdff2d8e43b1dd7f270bf112e2c4.bam	87.89	1.88	0.08	58cfa83ce4b0c9d6adf73128	c71bbdff2d8e43b1dd7f270bf112e2c4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A0J1-01A	EC7A9D74-8B3F-4747-8926-1739A016AB2B	Primary Tumor	Illumina HiSeq	4d43e1fb-f822-45ec-b3db-8b91f598ced3	Uterus	80	AC14E378-2DE1-458A-B8CD-7C60131AA927	950486AD-14F8-480A-B079-9CC3CD842090	TCGA-AX-A0J1-01A-11D-A066-09	GRCh37-lite	TCGA-AX-A0J1	TCGA-UCEC	NA	s5470	Washington University School of Medicine	Gynecologic Oncology Group	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf73184	58cfa83ce4b0c9d6adf73184	aa55b92d7a3d9eabf7f8c19d30f85566.filtered.	WGS	aa55b92d7a3d9eabf7f8c19d30f85566	aa55b92d7a3d9eabf7f8c19d30f85566.bam	60.12	1.87	0.07	58cfa83ce4b0c9d6adf73184	aa55b92d7a3d9eabf7f8c19d30f85566.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TC-01A	7B7D2D2B-ABE6-4F32-ADD0-3715096995D1	Primary Tumor	Illumina HiSeq	cfe5ac46-c8e7-4f91-a88f-bbbb286e9551	Uterus	69	C4C99327-B778-4E29-A111-75569AD38696	B0A83DF8-DD2C-4C1B-B238-9081D2C22258	TCGA-BS-A0TC-01A-11D-A10B-09	GRCh37-lite	TCGA-BS-A0TC	TCGA-UCEC	NA	s4395	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10B-09	TRUE
13722.58cfa83ce4b0c9d6adf73156	58cfa83ce4b0c9d6adf73156	a950fe8710031ec1f4934aa97d1d2437.filtered.	WGS	a950fe8710031ec1f4934aa97d1d2437	a950fe8710031ec1f4934aa97d1d2437.bam	96.72	1.83	0.07	58cfa83ce4b0c9d6adf73156	a950fe8710031ec1f4934aa97d1d2437.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TD-01A	FFAA98A0-2B69-46DC-AEE5-C5C3F2ABBC38	Primary Tumor	Illumina HiSeq	d09c860a-701a-48f3-bace-b479e65e7493	Uterus	65	8BB3A057-8958-4F62-AF81-976DA2E92DF7	712BA532-FB1A-43FA-A356-B446B509CEB7	TCGA-BS-A0TD-01A-11D-A10B-09	GRCh37-lite	TCGA-BS-A0TD	TCGA-UCEC	NA	s5179	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10B-09	TRUE
13722.58cfa83ce4b0c9d6adf730d4	58cfa83ce4b0c9d6adf730d4	fe7b56f09624164caf93abc1f8d3bdc7.filtered.	WGS	fe7b56f09624164caf93abc1f8d3bdc7	fe7b56f09624164caf93abc1f8d3bdc7.bam	34.51	1.9	0.08	58cfa83ce4b0c9d6adf730d4	fe7b56f09624164caf93abc1f8d3bdc7.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0WX-01A	A482FC4C-FF1D-46A0-A968-7DF06422CC4B	Primary Tumor	Illumina HiSeq	1d0beca4-681e-4dbe-a6cf-f6c492c370b2	Breast	40	7DAA9124-2878-4708-AE74-28B17EF4898C	47B5D831-5287-4F62-B17A-6E5EFF2E4184	TCGA-B6-A0WX-01A-11D-A10G-09	GRCh37-lite	TCGA-B6-A0WX	TCGA-BRCA	653	s6109	Washington University School of Medicine	Duke	United States	NO	T3	N1b	Other  specify	Stage IIIA	A10G-09	FALSE
13722.58cfa83ce4b0c9d6adf73060	58cfa83ce4b0c9d6adf73060	a3d780740258da56025b3a939d1ea7d5.filtered.	WGS	a3d780740258da56025b3a939d1ea7d5	a3d780740258da56025b3a939d1ea7d5.bam	57.22	2.05	0.08	58cfa83ce4b0c9d6adf73060	a3d780740258da56025b3a939d1ea7d5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0YG-01A	C0892598-1F7B-4F23-9CD8-731F797753D5	Primary Tumor	Illumina HiSeq	64d3bdd6-809b-4c4e-bb57-71f60383b777	Breast	63	5006C942-BC9A-41CB-8674-2341B4E66230	4D409156-3A36-4C63-9AD6-B6AF34F27B06	TCGA-A2-A0YG-01A-21D-A19H-09	GRCh37-lite	TCGA-A2-A0YG	TCGA-BRCA	NA	s6747	Washington University School of Medicine	Walter Reed	None	NO	T2	N3a	Infiltrating Ductal Carcinoma	Stage IIIC	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf731cc	58cfa83ce4b0c9d6adf731cc	c60fa4aad576f1b3b720d3433a80345f.filtered.	WGS	c60fa4aad576f1b3b720d3433a80345f	c60fa4aad576f1b3b720d3433a80345f.bam	13.75	NA	0.07	58cfa83ce4b0c9d6adf731cc	c60fa4aad576f1b3b720d3433a80345f.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LY-01B	3505F91D-BC66-4732-84B6-18C5B32CA6B8	Primary Tumor	Illumina HiSeq	0f2523c6-fd2e-49ae-b8d1-eb4f0fd50867	Mesenchymal	66	A5697D2C-8E1A-42BE-8EBF-E57D6919BA65	DF4366C4-170F-4233-B577-A8EA277B069C	TCGA-DX-A3LY-01B-11D-A27P-09	GRCh37-lite	TCGA-DX-A3LY	TCGA-SARC	NA	s2629	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A27P-09	FALSE
13722.58cfa83ce4b0c9d6adf72fea	58cfa83ce4b0c9d6adf72fea	f32bb0a94af8c21ac01c1ee17a7056ce.filtered.	WGS	f32bb0a94af8c21ac01c1ee17a7056ce	f32bb0a94af8c21ac01c1ee17a7056ce.bam	79.8	2.05	0.08	58cfa83ce4b0c9d6adf72fea	f32bb0a94af8c21ac01c1ee17a7056ce.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A09I-01A	1557183C-AEDD-4DF6-B98A-3654667F7B69	Primary Tumor	Illumina HiSeq	767c9f80-f27b-4abe-91c6-394a72835d7a	Breast	84	A09A99F9-33E3-45D5-BFC2-F57CE149A527	987D41EE-6BAB-490C-B0F2-BF28C0089DE9	TCGA-A8-A09I-01A-22D-A19H-09	GRCh37-lite	TCGA-A8-A09I	TCGA-BRCA	NA	s6615	Washington University School of Medicine	Indivumed	Germany	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf72f14	58cfa83ce4b0c9d6adf72f14	e52ff8a7016a0eac7ed93be3b1a7cfa2.filtered.	WGS	e52ff8a7016a0eac7ed93be3b1a7cfa2	e52ff8a7016a0eac7ed93be3b1a7cfa2.bam	90.97	2.13	0.08	58cfa83ce4b0c9d6adf72f14	e52ff8a7016a0eac7ed93be3b1a7cfa2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LO-01A	A081DA6F-51F3-4555-A6B8-736F8C6CDA39	Primary Tumor	Illumina HiSeq	41a58f7b-d910-420e-ae2c-d37cc1f4a220	Uterus	45	9846D8F3-5B22-48E9-B972-A0FE9F509FB4	A0E317B1-3F3B-4D25-B2D9-FCC2211DFDA3	TCGA-AP-A0LO-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0LO	TCGA-UCEC	1016	s5372	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa82de4b0c9d6adf6a461	58cfa82de4b0c9d6adf6a461	077f179af5b7fe13cbfcc88a10123c85.filtered.	WGS	077f179af5b7fe13cbfcc88a10123c85	077f179af5b7fe13cbfcc88a10123c85.bam	83.7	1.97	0.08	58cfa82de4b0c9d6adf6a461	077f179af5b7fe13cbfcc88a10123c85.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1MI-01A	941F75A1-FEA4-4539-BA69-60BB11608F6D	Primary Tumor	Illumina HiSeq	e32cf6ef-190c-4456-b8a7-b40b9c9c8036	Cervix	50	A753BCF7-82D6-4FB1-AF0D-641898BBFF9C	14B8BBF2-310B-459B-B52D-A7EF510CE1CF	TCGA-C5-A1MI-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1MI	TCGA-CESC	1083	s1508	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b1	N1	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a48c	58cfa82de4b0c9d6adf6a48c	01e2ea9ed2554ea6df56ed963414b511.filtered.	WGS	01e2ea9ed2554ea6df56ed963414b511	01e2ea9ed2554ea6df56ed963414b511.bam	33.83	1.84	0.08	58cfa82de4b0c9d6adf6a48c	01e2ea9ed2554ea6df56ed963414b511.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A26G-01A	5ED024E8-D05E-4C65-9441-EDA9930CCC82	Primary Tumor	Illumina HiSeq	f7140aea-8ed7-4d5d-adfb-bd360e319805	Breast	50	F0CF4ACD-6B09-4538-B58C-E86C623B6C71	36D1A85E-A09B-4537-86E0-EAF1EB03AED8	TCGA-A7-A26G-01A-21D-A167-09	GRCh37-lite	TCGA-A7-A26G	TCGA-BRCA	NA	s6110	Washington University School of Medicine	Christiana Healthcare	United States	NO	T2	N0 (i+)	Other  specify	Stage IIA	A167-09	FALSE
13722.58cfa82de4b0c9d6adf6a4b4	58cfa82de4b0c9d6adf6a4b4	30e285b326196b3c05f1a202424a5b2f.filtered.	WGS	30e285b326196b3c05f1a202424a5b2f	30e285b326196b3c05f1a202424a5b2f.bam	53.44	1.91	0.08	58cfa82de4b0c9d6adf6a4b4	30e285b326196b3c05f1a202424a5b2f.bam	Dead	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TE-01A	09066FBF-6A1D-46C9-A4C5-C53340C3D1BA	Primary Tumor	Illumina HiSeq	18f27937-fb61-45fa-92f4-eacb3b722603	Uterus	35	2D1226A1-1C88-422B-9A8D-316BEBEB65FD	AF96DB5A-684F-41D1-A910-5A5193393D9C	TCGA-BS-A0TE-01A-11D-A10B-09	GRCh37-lite	TCGA-BS-A0TE	TCGA-UCEC	146	s4581	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10B-09	TRUE
13722.58cfa82de4b0c9d6adf6a4ea	58cfa82de4b0c9d6adf6a4ea	282e52fc396cb531fa21b3436906608f.filtered.	WGS	282e52fc396cb531fa21b3436906608f	282e52fc396cb531fa21b3436906608f.bam	35.31	NA	0.08	58cfa82de4b0c9d6adf6a4ea	282e52fc396cb531fa21b3436906608f.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3Y0-01A	174850B4-5EC2-462B-A890-89BD1716B3C2	Primary Tumor	Illumina HiSeq	f1452ca5-f44b-4f35-a5eb-a8b1f9c44ef7	Breast	57	CAA2D510-9024-4D7D-B0EF-80FA4BE1E2EE	D8FBB398-D1DA-4444-984A-22C8523625DA	TCGA-A2-A3Y0-01A-11D-A23C-09	GRCh37-lite	TCGA-A2-A3Y0	TCGA-BRCA	NA	s6910	Washington University School of Medicine	Walter Reed	United States	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A23C-09	FALSE
13722.58cfa82de4b0c9d6adf6a510	58cfa82de4b0c9d6adf6a510	3ef8e47cf81ea29f26bf77c4c33b453f.filtered.	WGS	3ef8e47cf81ea29f26bf77c4c33b453f	3ef8e47cf81ea29f26bf77c4c33b453f.bam	80.41	NA	0.08	58cfa82de4b0c9d6adf6a510	3ef8e47cf81ea29f26bf77c4c33b453f.bam	Alive	FEMALE	Not available	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-DG-A2KJ-01A	7C93642D-7E05-40F8-B1EF-A014EDCFBA42	Primary Tumor	Illumina HiSeq	4399a247-c12c-480e-bc92-cf902a8a0a69	Cervix	50	4C1108C0-ED8A-4CAF-9417-DDFB6352C61E	8BE2B0F5-7BAD-4720-B13C-E95B32BDB933	TCGA-DG-A2KJ-01A-11D-A18J-09	GRCh37-lite	TCGA-DG-A2KJ	TCGA-CESC	NA	s1348	Washington University School of Medicine	Ontario Institute for Cancer Research	Canada	NO	T1b	N1	Cervical Squamous Cell Carcinoma	Not available	A18J-09	TRUE
13722.58cfa82de4b0c9d6adf6a64a	58cfa82de4b0c9d6adf6a64a	7e4be797a621ce82629293065b38f858.filtered.	WGS	7e4be797a621ce82629293065b38f858	7e4be797a621ce82629293065b38f858.bam	13.63	NA	0.09	58cfa82de4b0c9d6adf6a64a	7e4be797a621ce82629293065b38f858.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2LV-01A	00BCA18C-B3D4-45A3-8F19-034CC40449A4	Primary Tumor	Illumina HiSeq	559f9675-671e-41a5-b073-7782ab8b5542	Cervix	36	CBAD0C55-915A-4F65-B040-57111EAD3BDE	3269608C-5DD7-452A-976A-31AC971AAC2F	TCGA-C5-A2LV-01A-11D-A18J-09	GRCh37-lite	TCGA-C5-A2LV	TCGA-CESC	NA	s1354	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b	N1	Cervical Squamous Cell Carcinoma	Not available	A18J-09	TRUE
13722.58cfa82de4b0c9d6adf6a6fa	58cfa82de4b0c9d6adf6a6fa	9ae1429cc5f7f8e4692281baf49e4ff5.filtered.	WGS	9ae1429cc5f7f8e4692281baf49e4ff5	9ae1429cc5f7f8e4692281baf49e4ff5.bam	55.4	1.9	0.08	58cfa82de4b0c9d6adf6a6fa	9ae1429cc5f7f8e4692281baf49e4ff5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RT-01A	4BF50455-9AB7-4521-A791-089F66D3B877	Primary Tumor	Illumina HiSeq	0058348e-638c-426a-9fba-b26a3143c45b	Breast	39	C2300B5B-43A7-43B8-8CD1-22FF7E89A21A	1BB3A1C7-4D7B-4FB6-B54D-E94CBD0E32AA	TCGA-B6-A0RT-01A-21D-A128-09	GRCh37-lite	TCGA-B6-A0RT	TCGA-BRCA	NA	s5635	Washington University School of Medicine	Duke	United States	NO	T3	N1	Infiltrating Ductal Carcinoma	Stage IIIA	A128-09	TRUE
13722.58cfa82de4b0c9d6adf6a5ee	58cfa82de4b0c9d6adf6a5ee	6979f0583ba67718dda7c5ddb907abd8.filtered.	WGS	6979f0583ba67718dda7c5ddb907abd8	6979f0583ba67718dda7c5ddb907abd8.bam	77.7	2.03	0.08	58cfa82de4b0c9d6adf6a5ee	6979f0583ba67718dda7c5ddb907abd8.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J2-01A	D2F2560C-EC80-4FEA-9474-C47A2E85EA95	Primary Tumor	Illumina HiSeq	46cbf954-a4fb-4060-818c-a60666ae41d3	Breast	41	4F5E142F-D936-469D-ABAA-37BAF6F045AF	207F8A42-5B05-4876-B0AE-EBFAEEA27844	TCGA-AO-A0J2-01A-11D-A19H-09	GRCh37-lite	TCGA-AO-A0J2	TCGA-BRCA	NA	s6459	Washington University School of Medicine	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a49e	58cfa82de4b0c9d6adf6a49e	3d2308f4fcb270a0468e663dc68d9a50.filtered.	WGS	3d2308f4fcb270a0468e663dc68d9a50	3d2308f4fcb270a0468e663dc68d9a50.bam	60.36	1.92	0.07	58cfa82de4b0c9d6adf6a49e	3d2308f4fcb270a0468e663dc68d9a50.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A094-01A	993103B1-E5A1-4C33-8629-BE53EBC41D64	Primary Tumor	Illumina HiSeq	d706598d-75e8-4df1-94b7-da37b3361303	Breast	75	A36231AA-F304-4BBF-AA86-B9547916C097	DB45D81F-695C-4F99-BEEA-6DBEC1FF47FC	TCGA-A8-A094-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A094	TCGA-BRCA	NA	s6618	Washington University School of Medicine	Indivumed	Germany	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a4d6	58cfa82de4b0c9d6adf6a4d6	4042a719096f3096b3cbb539a45e6492.filtered.	WGS	4042a719096f3096b3cbb539a45e6492	4042a719096f3096b3cbb539a45e6492.bam	47.52	2	0.07	58cfa82de4b0c9d6adf6a4d6	4042a719096f3096b3cbb539a45e6492.bam	Alive	FEMALE	Not available	HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JM-01A	44BEC761-B603-49C0-8634-F6BFE0319BB1	Primary Tumor	Illumina HiSeq	456682bf-18d1-4383-96ba-6e06fe7dd669	Breast	40	7EC2C455-D90F-4CD5-9BBB-AEDBF21ECA00	AACABA97-ECDE-440B-AAE0-0E9C608C4B24	TCGA-AO-A0JM-01A-21D-A19H-09	GRCh37-lite	TCGA-AO-A0JM	TCGA-BRCA	NA	s5628	Washington University School of Medicine	MSKCC	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf730b4	58cfa83ce4b0c9d6adf730b4	fae749c6bcfc193aa1b9126628a2cf23.filtered.	WGS	fae749c6bcfc193aa1b9126628a2cf23	fae749c6bcfc193aa1b9126628a2cf23.bam	116.59	1.95	0.07	58cfa83ce4b0c9d6adf730b4	fae749c6bcfc193aa1b9126628a2cf23.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IJ-01A	2C86C3EA-D926-4D39-A5AE-39ECE4774287	Primary Tumor	Illumina HiSeq	b665cc0b-5952-419e-87a4-d97d3298f607	Breast	42	9EF8142A-8627-4DCF-8C87-15B1BC2BFEA2	B7FAC67C-EB7A-485C-A9B3-3E36388D02B1	TCGA-B6-A0IJ-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0IJ	TCGA-BRCA	NA	s6907	Washington University School of Medicine	Duke	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf73104	58cfa83ce4b0c9d6adf73104	bbb8b1b82e376eb4e8ac399b06def113.filtered.	WGS	bbb8b1b82e376eb4e8ac399b06def113	bbb8b1b82e376eb4e8ac399b06def113.bam	64.8	2.03	0.08	58cfa83ce4b0c9d6adf73104	bbb8b1b82e376eb4e8ac399b06def113.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I6-01A	045C13EF-3DB7-4ADF-B0A3-23338F0479F3	Primary Tumor	Illumina HiSeq	aea89793-bb38-432a-ab2c-b5b9e7e93b1c	Breast	49	14423610-4958-43F4-9A75-1A61C1293024	A876398C-5B1D-444F-A360-5FE2DB697480	TCGA-B6-A0I6-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0I6	TCGA-BRCA	991	s5621	Washington University School of Medicine	Duke	United States	NO	T1c	N1	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa82de4b0c9d6adf6a534	58cfa82de4b0c9d6adf6a534	49320cdd49b83c21082251cf7413af62.filtered.	WGS	49320cdd49b83c21082251cf7413af62	49320cdd49b83c21082251cf7413af62.bam	NA	NA	0.08	58cfa82de4b0c9d6adf6a534	49320cdd49b83c21082251cf7413af62.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A051-01A	B045F24B-F822-4DF9-9FFA-47308EDCEC8C	Primary Tumor	Illumina HiSeq	16685246-b33b-4810-9cef-2ec37924f621	Uterus	69	417CFF62-B034-4197-9CFD-E640D55F3094	BCF858FD-CC3B-4FDE-AB10-EB96216F4366	TCGA-AP-A051-01A-21D-A013-09	GRCh37-lite	TCGA-AP-A051	TCGA-UCEC	NA	s5190	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa82de4b0c9d6adf6a577	58cfa82de4b0c9d6adf6a577	4d55b306c9f948c74d83dd41705f0440.filtered.	WGS	4d55b306c9f948c74d83dd41705f0440	4d55b306c9f948c74d83dd41705f0440.bam	91.17	1.76	0.08	58cfa82de4b0c9d6adf6a577	4d55b306c9f948c74d83dd41705f0440.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1MQ-01A	EB59CF69-1997-41B9-BF69-69AD7DA292A1	Primary Tumor	Illumina HiSeq	6eef85cb-d9eb-495a-b69a-6944cbd18483	Cervix	35	F5FC27D9-4949-43E9-B358-78CB69D87A3C	A67F4531-99EF-43DF-82F5-F6ABC4B11826	TCGA-C5-A1MQ-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1MQ	TCGA-CESC	NA	s1163	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T2b	N0	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a666	58cfa82de4b0c9d6adf6a666	804182419c4c4708dc5058194c29d6d2.filtered.	WGS	804182419c4c4708dc5058194c29d6d2	804182419c4c4708dc5058194c29d6d2.bam	22.3	NA	0.08	58cfa82de4b0c9d6adf6a666	804182419c4c4708dc5058194c29d6d2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LT-01A	E7A72F7E-77B1-4D95-8F37-39A6CFFC35DC	Primary Tumor	Illumina HiSeq	3daa0a7d-91d3-4cad-a48a-5a08bdd32529	Mesenchymal	62	32F8354A-7D2F-467B-AFED-E7F91369615F	A2F02FF7-8433-4CB5-9324-34F13EDEACA1	TCGA-DX-A3LT-01A-12D-A21Q-09	GRCh37-lite	TCGA-DX-A3LT	TCGA-SARC	NA	s2490	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82fe4b0c9d6adf6b8e0	58cfa82fe4b0c9d6adf6b8e0	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.filtered.	WGS	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.bam	40.39	1.89	0.07	58cfa82fe4b0c9d6adf6b8e0	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A0CE-01A	9D95A65B-E41D-4F93-92D4-99DCE29FF40D	Primary Tumor	Illumina HiSeq	d744c7c6-690c-4f5e-968e-532936b3696a	Breast	57	9DC315CE-3B76-4754-B103-2C2580CDE4AB	7B08E810-F3C9-4155-AC11-F45A3A4F8B41	TCGA-A7-A0CE-01A-11D-A12L-09	GRCh37-lite	TCGA-A7-A0CE	TCGA-BRCA	NA	s5490	Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A12L-09	FALSE
13722.58cfa82fe4b0c9d6adf6b948	58cfa82fe4b0c9d6adf6b948	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	91.2	1.92	0.08	58cfa82fe4b0c9d6adf6b948	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04T-01A	B58AD350-5140-4FA8-BC2C-24BCA8395F3A	Primary Tumor	Illumina HiSeq	6dd42df3-896f-418a-9f13-468ac66d69bc	Breast	62	6DD4870F-1EC2-484B-8703-6397D8E67DAA	B752B444-F033-4BE4-9D24-E5E80B4181AF	TCGA-A2-A04T-01A-21D-A128-09	GRCh37-lite	TCGA-A2-A04T	TCGA-BRCA	NA	s5637	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6bc2c	58cfa830e4b0c9d6adf6bc2c	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	78.64	1.86	0.08	58cfa830e4b0c9d6adf6bc2c	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J4-01A	A9B7D7FE-BE31-4F71-AFEE-C1BFDF511888	Primary Tumor	Illumina HiSeq	b518df9f-2eae-4c82-92e3-3eb196cdd3a5	Breast	41	CF11642A-EB96-4B37-B914-371C71F8E0CA	110B5F05-DED7-45EC-B0F6-A941C92D77DD	TCGA-AO-A0J4-01A-11D-A128-09	GRCh37-lite	TCGA-AO-A0J4	TCGA-BRCA	NA	s5960	Washington University School of Medicine	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6bbae	58cfa830e4b0c9d6adf6bbae	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	61.59	1.89	0.08	58cfa830e4b0c9d6adf6bbae	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D2-01A	99E32C59-AA73-43FA-88C9-399DDADB2C72	Primary Tumor	Illumina HiSeq	221d4b81-a70e-4647-8a9a-ce4866538392	Breast	45	72439E36-3C17-4A90-B3E1-8F6CCFD3DCD4	51A5A15A-1551-469F-A5B0-09581EC47975	TCGA-A2-A0D2-01A-21D-A128-09	GRCh37-lite	TCGA-A2-A0D2	TCGA-BRCA	NA	s5488	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i+)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6bdc6	58cfa830e4b0c9d6adf6bdc6	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	52.29	1.9	0.08	58cfa830e4b0c9d6adf6bdc6	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0B3-01A	18EB4DFC-556F-4BF3-A411-4780209ED1E0	Primary Tumor	Illumina HiSeq	82535082-739b-4a9b-8609-4724bbdd27ee	Breast	53	FC1F0AD4-8412-4143-8EBF-FA6592F396E9	43F7A2E0-FEC9-4E43-872D-18C6C946FA17	TCGA-BH-A0B3-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0B3	TCGA-BRCA	NA	s6464	Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6bdd8	58cfa830e4b0c9d6adf6bdd8	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	55.87	1.93	0.08	58cfa830e4b0c9d6adf6bdd8	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0E0-01A	20E8106B-1290-4735-ABE4-7621E08E3DC8	Primary Tumor	Illumina HiSeq	fc737335-21e7-4997-b267-04d3f91043f5	Breast	38	662CC11C-DA31-4E31-8E77-46011B38EA96	E8392F20-C9E3-4649-B64F-5B266C393A76	TCGA-BH-A0E0-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0E0	TCGA-BRCA	NA	s5804	Washington University School of Medicine	University of Pittsburgh	None	NO	T3	N3a	Infiltrating Ductal Carcinoma	Stage IIIC	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6c1ea	58cfa830e4b0c9d6adf6c1ea	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	73.05	2	0.08	58cfa830e4b0c9d6adf6c1ea	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J6-01A	E9F4F373-37A5-48AD-A1A0-B0D47820111A	Primary Tumor	Illumina HiSeq	71b1d18c-e0ab-473a-b4ee-55ebb68cfda8	Breast	61	0C12EA89-EEB4-4865-91EB-10CF75884C21	F69E5057-EDA6-4391-BA9A-AEDBF6B572DA	TCGA-AO-A0J6-01A-11D-A128-09	GRCh37-lite	TCGA-AO-A0J6	TCGA-BRCA	NA	s5798	Washington University School of Medicine	MSKCC	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf72efc	58cfa83ce4b0c9d6adf72efc	bc77bc34a99fd3e3ca9ff72ebb9852f8.filtered.	WGS	bc77bc34a99fd3e3ca9ff72ebb9852f8	bc77bc34a99fd3e3ca9ff72ebb9852f8.bam	21.25	NA	0.08	58cfa83ce4b0c9d6adf72efc	bc77bc34a99fd3e3ca9ff72ebb9852f8.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-HB-A5W3-01A	C5B0E6BE-48B5-40E5-9D90-F9112050AA88	Primary Tumor	Illumina HiSeq	49c1bf65-391c-43e5-97fe-2f34ca184442	Mesenchymal	58	E7E97623-5C8A-42B4-ABC6-E7B424816713	4D4EFF82-EDE0-47F1-B49A-ADA025952114	TCGA-HB-A5W3-01A-11D-A29N-09	GRCh37-lite	TCGA-HB-A5W3	TCGA-SARC	384	s2669	Washington University School of Medicine	University of North Carolina	United States	NO	Not available	Not available	Not available	Not available	A29N-09	FALSE
13722.58cfa83ce4b0c9d6adf72f0f	58cfa83ce4b0c9d6adf72f0f	d70abbce939febed4d88a2f3041db471.filtered.	WGS	d70abbce939febed4d88a2f3041db471	d70abbce939febed4d88a2f3041db471.bam	97.91	1.93	0.08	58cfa83ce4b0c9d6adf72f0f	d70abbce939febed4d88a2f3041db471.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A1NU-01A	E56491AF-718F-4CA1-B3CD-0E5B3154697B	Primary Tumor	Illumina HiSeq	55250c6d-b9fb-4613-8463-59123f4e2065	Uterus	74	7901F084-C220-4865-A034-DA0144D63A28	FD504153-3CF6-44B9-99D5-21961EBAC188	TCGA-D1-A1NU-01A-11D-A34H-09	GRCh37-lite	TCGA-D1-A1NU	TCGA-UCEC	NA	s4399	Washington University School of Medicine	Mayo Clinic	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A34H-09	TRUE
13722.58cfa82de4b0c9d6adf6a5dc	58cfa82de4b0c9d6adf6a5dc	5c54cebf17d98a845d11ad5d5185f4a0.filtered.	WGS	5c54cebf17d98a845d11ad5d5185f4a0	5c54cebf17d98a845d11ad5d5185f4a0.bam	37.22	1.8	0.07	58cfa82de4b0c9d6adf6a5dc	5c54cebf17d98a845d11ad5d5185f4a0.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RU-01A	6956473B-92E5-4069-A26B-B48E280E76F2	Primary Tumor	Illumina HiSeq	2efc5248-9be4-4e98-a400-f2ee744ac29d	Breast	40	C94232F8-2E37-46D0-B12A-B8E920E659D9	97064332-1D4F-4571-93FF-354FFE6D7DF9	TCGA-B6-A0RU-01A-11D-A12L-09	GRCh37-lite	TCGA-B6-A0RU	TCGA-BRCA	NA	s5950	Washington University School of Medicine	Duke	United States	NO	T1c	N0 (i-)	Other  specify	Stage IA	A12L-09	FALSE
13722.58cfa830e4b0c9d6adf6ba6a	58cfa830e4b0c9d6adf6ba6a	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.bam	66.09	2.03	0.08	58cfa830e4b0c9d6adf6ba6a	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04P-01A	CCD4A24B-D8CC-4686-9DEE-C98B0C5A8D21	Primary Tumor	Illumina HiSeq	680a94d4-95ae-4e50-b380-28f9f3c3be71	Breast	36	E4DEE88B-58D0-4953-AD4A-A2DF876F3C95	A85CF239-FF51-46E7-9B88-4C2CB49C66B9	TCGA-A2-A04P-01A-31D-A128-09	GRCh37-lite	TCGA-A2-A04P	TCGA-BRCA	548	s5958	Washington University School of Medicine	Walter Reed	None	NO	T2	N3c	Infiltrating Ductal Carcinoma	Stage IIIC	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6be26	58cfa830e4b0c9d6adf6be26	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	63.5	1.95	0.07	58cfa830e4b0c9d6adf6be26	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0WA-01A	786E8DBE-442E-4551-87B3-B4C333B04DD4	Primary Tumor	Illumina HiSeq	1671f5e8-9bbd-41c1-803e-c518d5ba004f	Breast	82	8EF7AD6F-A6E4-405C-B20E-D547985BD9D6	EDDFBFB9-3AE8-449B-B870-46062A2571C1	TCGA-BH-A0WA-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0WA	TCGA-BRCA	NA	s6631	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0 (i-)	Not available	Stage I	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf73090	58cfa83ce4b0c9d6adf73090	f6f0bc109f78a22318fcd55e02cd9e0e.filtered.	WGS	f6f0bc109f78a22318fcd55e02cd9e0e	f6f0bc109f78a22318fcd55e02cd9e0e.bam	54.22	1.93	0.08	58cfa83ce4b0c9d6adf73090	f6f0bc109f78a22318fcd55e02cd9e0e.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0G9-01A	45D58088-D3F4-4EB0-B75C-BCB98C0981DC	Primary Tumor	Illumina HiSeq	5394f784-0e1a-4fe2-82e6-a4ba4d7f95b4	Uterus	79	117A5B33-42C5-4A52-BABE-D9712F3E7472	EAE45FBE-9F7D-4F59-A0A9-1F0F0D69AFC4	TCGA-A5-A0G9-01A-11D-A066-09	GRCh37-lite	TCGA-A5-A0G9	TCGA-UCEC	NA	s4575	Washington University School of Medicine	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
